Novel 1, 2, 4-oxadiazole compounds as fungicides

By developing novel 1,2,4-oxadiazole compounds and their combinations, the problem of insufficient fungicidal activity of existing oxadiazole compounds has been solved, achieving highly efficient control of plant pathogenic microorganisms, expanding the scope of application, and improving the effect at low doses.

CN122094943APending Publication Date: 2026-05-26PI IND LTD
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
CN202480068630.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2023-09-08
Filing Date
2024-09-08
Publication Date
2026-05-26

AI Technical Summary

Technical Problem

Existing oxadiazole compounds have problems with narrow application range or unsatisfactory activity in terms of fungicidal activity, especially at low application doses.

Method used

Develop novel 1,2,4-oxadiazole compounds and their salts, stereoisomers, polymorphs or N-oxides for the preparation of fungicides, and combine them with surfactants and other bioactive compounds to form fungicidal compositions for the control of plant pathogenic microorganisms.

Benefits of technology

It improves the fungicidal activity against plant pathogenic microorganisms, expands the scope of application, and enhances the effect at low application doses.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN122094943A_ABST
    Figure CN122094943A_ABST
Patent Text Reader

Abstract

The invention relates to a novel 1, 2, 4-oxadiazole compound (I) as a fungicide, in which A1, R1, R2, R3, R4 and R5 are defined in the specification. The invention also discloses a preparation method of the compound of the formula (I) and application of the compound as a fungicide. (I)
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to compounds of formula (I). More specifically, this invention relates to novel 1,2,4-oxadiazole compounds of formula (I) and methods for their preparation. This invention also relates to compositions comprising compounds of formula (I) and their use in agriculture or horticulture for controlling or preventing pests on plants, harvested food crops, seeds, or abiotic materials, preferably controlling plant pathogenic microorganisms (e.g., fungi). Background Technology

[0002] A variety of oxadiazole compounds with fungicidal activity have been disclosed in the literature. For example, WO2018117034, WO2018153730 and WO2018114393 disclose a variety of oxadiazole compounds as fungicides.

[0003] WO2020027214, JP2020079269, WO2020165403 and WO2020079111 disclose methoxyacrylate compounds with antifungal activity.

[0004] WO1999067209 discloses compounds based on oxadiazole, wherein the compounds have fungicidal, insecticidal, acaricidal and nematicidal activities.

[0005] The oxadiazole compounds reported in these documents have certain shortcomings, such as a narrow range of applications or unsatisfactory insecticidal and / or fungicidal activity, especially at low application doses.

[0006] Therefore, the object of the present invention is to provide compounds that have improving / enhancing activity against plant pathogenic microorganisms (e.g., fungi).

[0007] This objective is achieved through 1,2,4-oxadiazole compounds and their application in agriculture or horticulture, including the control or prevention of infection of plants, harvested food crops, seeds or abiotic materials by plant pathogenic microorganisms (preferably fungi). Summary of the Invention

[0008] Therefore, the present invention provides 1,2,4-oxadiazole compounds or their salts, stereoisomers, polymorphs or N-oxides.

[0009]

[0010] (I) Among them, A 1 R 1 R 2 R 3 R 4 and R 5 See the detailed description for the definition.

[0011] In one embodiment, the present invention provides a method for preparing a compound of formula (I) or a salt thereof.

[0012] In another embodiment, the present invention provides a composition for controlling or preventing plant pathogenic microorganisms (preferably fungi), the composition comprising a bioavailable amount of a compound of formula (I) or a salt thereof, a stereoisomer, a polymorph or an N-oxide, and at least one additional component selected from surfactants and auxiliaries.

[0013] In another embodiment, the present invention provides a composition further comprising at least one additional biologically active and compatible compound selected from fungicides, insecticides, nematicides, acaricides, biopesticides, herbicides, plant growth regulators, antibiotics, fertilizers, or nutrients.

[0014] In yet another embodiment, the present invention provides the use of a compound of formula (I) or its salts, stereoisomers, polymorphs or N-oxides as a fungicide.

[0015] In yet another embodiment, the present invention provides a fungicidal composition comprising a compound of formula (I), which can be used for the therapeutic or preventative control of plant pathogenic fungi on plants or crops.

[0016] In another embodiment, the present invention provides a method for the therapeutic or preventative control of plant pathogenic fungi in plants or crops, characterized in that a compound of formula (I) or a fungicidal composition according to the present invention is applied to seeds, plants or fruits of plants, or to the soil in which the respective plants grow or are intended to grow.

[0017] In another embodiment, the present invention provides the use of the compound of formula (I) against resistant soybean rust fungus with F129L amino acid substitution in mitochondrial cytochrome b protein. Detailed Implementation

[0018] definition Before describing exemplary embodiments of the present invention in detail, some definitions essential for understanding the invention are provided. In this specification and the appended claims, the singular forms of “a” and “an” also include their corresponding plural forms, unless the context otherwise requires. In the context of this invention, the terms “about” and “approximately” indicate a range of precision that can be understood by those skilled in the art while still ensuring the effectiveness of the relevant features.

[0019] As used herein, the terms “comprising,” “including,” or any other similar expressions are intended to cover exclusive inclusion, but are subject to any expressly indicated limitations. For example, a composition, mixture, process, or method that comprises a list of elements is not necessarily limited to those elements and may also include other elements not expressly listed or specific to such composition, mixture, process, or method.

[0020] The transitional phrase "composed of..." excludes any unspecified element, step, or ingredient. If such a statement is included in a claim, the claim excludes materials other than impurities that are usually associated with it. When the phrase "composed of..." appears in a clause of the body of a claim, rather than immediately following the preamble, it limits the elements outlined in that clause only; other elements are not excluded from the entire claim. The term "agriculture" refers to the production of crops such as food and fiber, including maize, soybeans and other legumes, rice, cereals (such as wheat, oats, barley, rye, rice, maize), leafy vegetables (such as lettuce, cabbage, etc., rapeseed), fruit vegetables (such as tomatoes, peppers, eggplants, cruciferous wormwood), potatoes, sweet potatoes, grapes, cotton, tree fruits (such as citron, seeds, and citrus), small berries (berries, cherries) and other specialty crops (such as rapeseed), sunflowers, and olives.

[0021] As used herein, the term "halogen" or "halogenated" refers to fluoro, chloro, bromo, or iodo, preferably fluoro, chloro, or bromo. As used herein, the term "cyano" refers to the -CN group.

[0022] As used in this article, the term "hydroxyl group" refers to the -OH group.

[0023] As used in this article, the term "C1-C" n "-alkyl" refers to a straight-chain or branched hydrocarbon radical consisting only of carbon and hydrogen atoms, without unsaturated bonds, having 1 to n carbon atoms, and connected to the rest of the molecule by single bonds. It should be interpreted accordingly as C1-C8-alkyl, C1-C6-alkyl, C1-C4-alkyl, C1-C3-alkyl, and C1-C2-alkyl. nExamples of -alkyl groups include, but are not limited to: n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl or 1-ethyl-2-methylpropyl, preferably methyl, ethyl, n-propyl, 1-methylethyl, n-butyl, 1-dimethylethyl, n-pentyl or n-hexyl.

[0024] As used in this article, the term "C2-C" n "-Alkenyl" refers to a straight-chain or branched hydrocarbon radical composed only of carbon and hydrogen atoms, containing at least one double bond, which can be of (E)- or (+ / -) configuration, having 2 to n carbon atoms, and connected to the rest of the molecule by single bonds. It should be interpreted accordingly as C3-C6-alkenyl. C2-C nExamples of -alkenyl groups include, but are not limited to, vinyl, 1-propenyl, 2-propenyl, 1-methylvinyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 2-methyl-2-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl- 3-Butenyl, 3-methyl-3-butenyl, 1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-3-pentenyl, 1-methyl-2-pentenyl, 3-methyl-1-pentenyl, 3-methyl-pentenyl, 2-methyl-pentenyl, 3-methyl-2-pentenyl, 3,2-methyl-2-pentenyl, 3-methyl-2-pentenyl 4-Methyl-2-pentenyl, 1-Methyl-3-pentenyl, 2-Methyl-3-pentenyl, 3-Methyl-3-pentenyl, 4-Methyl-3-pentenyl, 1-Methyl-4-pentenyl, 2-Methyl-4-pentenyl, 3-Methyl-4-pentenyl, 4-Methyl-4-pentenyl, 1-Dimethyl-2-butenyl, 1-Dimethyl-3-butenyl, 1,2-Dimethyl-1-butenyl, 1,2-Dimethyl-2-butenyl, methyl-2-pentenyl, methyl-3-pentenyl, methyl-2-butenyl, 1,1,2-Dimethyl-3-butenyl, 1,3-Dimethyl-1-butenyl, 1,3-Dimethyl-2-butenyl, 1,3-Dimethyl-3-butenyl, 2-Dimethyl-3-butenyl 2,3-Dimethyl-1-butenyl, 2,3-Dimethyl-2-butenyl, 2,3-Dimethyl-3-butenyl, 3-Dimethyl-1-butenyl, 3-Dimethyl-2-butenyl, 1-Ethyl-1-butenyl, 1-Ethyl-2-butenyl, 1-Ethyl-3-butenyl, 2-Ethyl-1-butenyl, 2-Dimethyl-3-butenyl, 2-Dimethyl-2-butenyl, 2-Ethyl-1-butenyl, 2-Dimethyl, 2-Ethyl-2-butenyl, 2-Ethyl-3-butenyl, 1,2-Trimethyl-2-propenyl, 1-Ethyl-1-methyl-2-propenyl, 1-Ethyl-2-methyl-1-propenyl and 1-Ethyl-2-methyl-2-propenyl.

[0025] As used in this article, the term "C2-C" n "-haloalkenyl" refers to the C2-C group as broadly defined above. n -Alkenyl radical, and is replaced by one or more identical or different halogen atoms.

[0026] As used in this article, the term "C2-C" n "-Alkyne" refers to a straight-chain or branched hydrocarbon radical composed only of carbon and hydrogen atoms, containing at least one triple bond, having 2 to n carbon atoms, and connected to the rest of the molecule by single bonds. (C2-C) n Examples of -alkynyl groups include, but are not limited to: 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl The following are listed: 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1-dimethyl-2-butynyl, 1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2-dimethyl-3-butynyl, 3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-butynyl-propynyl.

[0027] As used in this article, the term "C2-C" n "-Halogen-alkynyl" refers to the C2-C group as broadly defined above. n -Alynyl radical, and is replaced by one or more identical or different halogen atoms.

[0028] As used herein, the term "cyano-C1-C6-alkyl-" refers to a C1-C6 alkyl radical as broadly defined above, which is substituted with one or more cyano groups.

[0029] As used herein, the term "C1-C6-alkoxy" refers to a straight-chain or branched saturated alkyl radical containing 1 to 6 carbon atoms linked by oxygen atoms. For example, it refers to a radical of the general formula -ORa, where Ra is a C1-C6-alkyl radical as broadly defined above. It should be interpreted accordingly as C1-C3-alkoxy. Examples of C1-C6 alkoxy radicals include, but are not limited to, methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentooxy, 1-methylbutoxy, 2-methylbutoxy, 3-methoxybutoxy, 1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-Methylpentoxy, 1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-dimethylpropoxy, 2-methylpropoxy, 2-dimethylpropoxy, 1,1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy.

[0030] As used herein, the term "C1-C6-haloalkyl" refers to a straight-chain or branched saturated C1-C6-alkyl radical, as generally defined above, substituted with one or more identical or different halogen atoms. It should be interpreted accordingly as C1-C4-haloalkyl or C1-C3-haloalkyl. Examples of C1-C6 haloalkyl include, but are not limited to, chloromethyl, fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl, and 2,2,2-trifluoroethyl, 5-fluoropentyl, 5-chloropentyl, 5-bromopentyl, 5-iodopentyl, undecylfluoropentyl, 6-fluorohexyl, 6-chlorohexyl, 6-bromohexyl, 6-iodohexyl, and dodecafluorohexyl.

[0031] As used herein, the term "C1-C6 haloalkoxy" refers to a straight-chain or branched saturated C1-C6 alkoxy group as defined above, substituted with one or more identical or different halogen atoms. It should be understood accordingly as C1-C4 haloalkoxy. Examples of C1-C6 haloalkoxy groups include, but are not limited to: for example, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2-Chloropropoxy, 3-Chloropropoxy, 2-Bromopropoxy, 3-Bromopropoxy, 2,2-Difluoropropoxy, 2,3-Difluoropropoxy, 2-Bromopropoxy, 2,3-Dichloropropoxy, 3,3,3-Trifluoropropoxy, 3,3,3-Trichloropropoxy, 2,3,3,3-Pentafluoropropoxy, Heptafluoropropoxy, 1-Fluoromethyl-2-Fluoroethoxy, 1-Chloromethyl-2-Chloroethoxy, 1-Bromomethyl-2-Bromoethoxy, 4-Fluorobutoxy, 4-Chlorobutoxy, 4-Bromobutoxy and Nonafluorobutoxy; As used herein, the term “C3-C6-cycloalkyl-C1-C4-alkoxy-” refers to a C1-C4-alkoxy radical as generally described above, which is substituted with one or more C3-C6-cycloalkyl groups as generally defined below.

[0032] As used herein, the term “C2-C6-olefin” refers to -ORa, where Ra is a C2-C6-olefin as described above.

[0033] As used herein, the term “C2-C6-alkynyloxy” refers to -ORa, where Ra is the C2-C6-alkynyl group as defined above.

[0034] As used herein, the term "C1-C6-alkoxy-C1-C6-alkyl" refers to a radical of the general formula Ra-O-Rb-, where Ra is a C1-C6-alkyl radical as generally defined above, and Rb is a C1-C6-alkylene radical as generally defined above. Examples of C1-C6-alkoxy-C1-C6-alkyl include, but are not limited to, ethoxymethyl, ethoxypropyl, and isopropoxymethyl.

[0035] As used herein, the terms “C1-C6-alkylthio” or “C1-C6-alkylthio” refer to a radical of the general formula -SRa, where Ra is a C1-C6-alkyl radical as broadly defined above.

[0036] As used herein, the term "C1-C6-haloalkylthio" refers to a C1-C6-alkylthio group as described above, which is substituted with one or more of the same or different halogen atoms.

[0037] As used herein, the term "C1-C6-alkylcarbonyl" refers to a radical of the general formula -C(O)Ra, where Ra is a C1-C6-alkyl radical as generally defined above. As used herein, the term "C1-C3-alkoxy-C1-C6-alkylthio" refers to a C1-C6-alkylthio group as described above, substituted with one or more C1-C3-alkoxy groups.

[0038] As used herein, the term “C3-C6-cycloalkyl-C1-C6-alkylthio” refers to a C1-C6-alkylthio group as defined above, which is substituted with one or more C3-C6-cycloalkyl groups as generally defined below.

[0039] As used herein, the term “C1-C6-alkylthio-C1-C3-alkyl-” refers to a radical of the general formula Ra-S-Rb-, where Ra is a C1-C3-alkyl radical as generally defined above, and Rb is a C1-C6-alkylene radical as generally defined above.

[0040] As used in this article, the term "C3-C" n "-Cycloalkyl" refers to ternary to n-membered cycloalkyl radicals. Examples include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, and cyclohexyl.

[0041] As used herein, the term "C3-C6-cycloalkoxy" refers to a tri- to six-membered cycloalkoxy radical. Examples include, but are not limited to, cyclopropoxy, cyclobutoxy, cyclopentoxy, and cyclohexoxy.

[0042] As used in this article, the term "C3-C" n "-Cycloalkenyl" refers to a stable, monocyclic, partially unsaturated cyclic radical containing 3 to n carbon atoms. It should be interpreted accordingly as C3-C4-cycloalkenyl. Examples of C3-C6-cycloalkenyl include, but are not limited to: 1-cyclopropenyl, 2-cyclopropenyl, 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 1,3-cyclopentadienyl, 1,4-cyclopentadienyl, 2,4-cyclopentadienyl, 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl, 1,4-cyclohexadienyl, and 2,5-cyclohexadienyl.

[0043] As used herein, the term "C3-C6-cycloalkyl-C1-C" n "-alkyl" refers to a C1-C1 alkyl group that has been substituted by one or more C3-C6-cycloalkyl groups as generally defined above. n-alkyl radical. Should be interpreted accordingly as C3-C6-cycloalkyl-C1-C3-alkyl. Examples include, but are not limited to, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclopentylethyl, and cyclohexylmethyl.

[0044] As used herein, the term “C3-C6-cycloalkyl-C2-C6-alkenyl-” refers to a C2-C6-alkenyl radical as generally defined above, which is substituted with one or more C3-C6-cycloalkyl groups as generally defined above.

[0045] As used herein, the term “C3-C6-cycloalkyl-C2-C6-ynyl-” refers to a C2-C6-ynyl radical as generally defined above, which is substituted with one or more C3-C6-cycloalkyl groups as generally defined above.

[0046] As used herein, the term "C3-C6-halocycloalkyl-" refers to a C3-C6-cycloalkyl radical as broadly defined above, substituted with one or more identical or different halogen atoms. It should be interpreted accordingly as C3-C4-halocycloalkyl-.

[0047] As used herein, the term "C3-C6-cycloalkoxy-C1-C3-alkyl-" refers to a C1-C3-alkyl group as generally defined above, substituted with a C3-C6-cycloalkoxy group. Examples include, but are not limited to, cyclopropoxymethyl, cyclobutoxymethyl, and cyclopentoxymethyl.

[0048] As used in this article, the term "4-10 member non-aromatic heterocycle" refers to a saturated or partially unsaturated non-aromatic monocyclic or bicyclic heterocycle.

[0049] As used herein, the term "4-10 membered non-aromatic heterocyclic-C1-C3-alkyl" refers to a C1-C3-alkyl group as broadly defined above, substituted with a 4-10 membered non-aromatic heterocycle. Examples include, but are not limited to, aziridine butylmethyl, oxadiazolyl methyl, imidazolyl methyl, aziridine butylethyl, oxadiazolyl ethyl, imidazolyl ethyl, hexahydropyrimidinylmethyl, piperazineylethyl, and oxadiazolylmethyl.

[0050] As used herein, the term "9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl" refers to a C1-C3-alkyl radical as generally defined above, substituted with a 9- or 10-membered bicyclic heteroaryl ring. Examples include, but are not limited to, quinolinylmethyl, quinolinylethyl, isoquinolinylmethyl, and isoquinolinylethyl.

[0051] As used herein, the term "4-10-membered non-aromatic heterocyclic-C1-C3-alkyl" refers to a C1-C3-alkyl radical as broadly defined above, substituted with a 4-10-membered non-aromatic heterocyclic ring. Examples include, but are not limited to, aziridine-butoxymethyl, oxadiazolidine-butoxymethyl, imidazolidine-butoxymethyl, aziridine-butoxyethyl, oxadiazolidine-butoxyethyl, imidazolidine-butoxyethyl, hexahydropyrimidine-butoxymethyl, piperazine-butoxyethyl, and oxadiazolidine-butoxymethyl.

[0052] As used herein, the term "5- or 6-membered heteroaryl-C1-C3-alkyl" refers to a C1-C3-alkyl group as generally defined above, which is substituted with a 5- or 6-membered heteroaryl ring. Examples include, but are not limited to, imidazolylmethyl, oxadiazolylmethyl, thiadiazolylmethyl, pyridylethyl, pyrazinylethyl, pyridylmethyl, pyrazinylmethyl, pyrimidinylmethyl, and pyrimidinylethyl.

[0053] As used herein, the term "5- to 10-membered heteroaryloxy-C1-C3-alkyl" refers to a C1-C3-alkyl radical as broadly defined above, substituted with a 5- to 10-membered heteroaryloxy ring. Examples include, but are not limited to, imidazolium oxymethyl, oxadiazolium oxymethyl, thiadiazolium oxymethyl, pyridinium oxyethyl, pyrazinium oxyethyl, pyridinium oxymethyl, pyrazinium oxymethyl, pyrimidine oxymethyl, pyrimidine oxyethyl, and dihydrobenzofuran-5-yloxymethyl.

[0054] As used herein, the term "phenyl-C1-C6-alkyl-" refers to a benzene ring attached to a C1-C6-alkylene radical as generally defined above.

[0055] As used herein, the term "phenoxy-C1-C6-alkyl-" refers to a benzene ring connected by an oxygen atom to a C1-C6-alkylene radical as generally defined above.

[0056] As used in this article, the term "C5-C" 12 "Saturated or partially unsaturated bicarbon or tricarbon rings" refers to 5 to 12-membered saturated or partially unsaturated bicarbon or tricarbon rings. - Bicyclic rings include, but are not limited to, fused bicyclic rings, such as decahydronaphthalene and octahydro-1H-indene; bridged bicyclic rings, such as bicyclic [4.3.1]decane and bicyclic [4.2.1]nonane; spirocyclic rings, such as, but not limited to, spiro[4.5]decane, spiro[2.3]hexane, spiro[2.2]pentane, spiro[3.3]heptane and spiro[2.4]heptane; and - Tricyclic rings include, but are not limited to, fused tricyclic rings, such as tetradecahydrobenzo[a]azine; bridged tricyclic rings, such as adamantyl; spirocyclic rings, such as dispiro[2.0.4] 4 .1 3 Nonane and dispirol [4.0.5] 6 .1 5 Dodecane.

[0057] As used herein, the term "aryl" refers to a group containing any carbon-based aromatic group, including but not limited to phenyl, naphthyl, biphenyl, anthracene, etc. Aryl groups can be substituted or unsubstituted. Furthermore, aryl groups can be monocyclic or polycyclic structures, which can be fused ring structures or linked by one or more bridging groups (e.g., carbon-carbon bonds).

[0058] Unless otherwise expressly stated, the term “heterogeneous” as used herein, in relation to a ring, means a ring in which at least one ring atom is not a carbon atom, and the ring may contain one to four heteroatoms independently selected from nitrogen, oxygen and sulfur, provided that each ring contains no more than four nitrogen atoms, no more than two oxygen atoms and no more than two sulfur atoms.

[0059] The term "aromatic" indicates compliance with the Hückel rule, while the term "non-aromatic" indicates non-compliance with the Hückel rule.

[0060] Unless otherwise explicitly defined, the terms "heterocyclic" or "heterocyclic" or "heterocyclic system" include "aromatic heterocyclic" or "heteroaryl bicyclic system" and "non-aromatic heterocyclic system" or polycyclic or bicyclic (spiro, fused, bridged, non-fused) cyclic compounds, wherein the ring can be aromatic or non-aromatic, and wherein the heterocyclic ring contains at least one element selected from N, O, and S(O). 0-2 And / or the carbocyclic member of the heterocycle can be replaced by C(=O), C(=S), C(=CR*R*) and C=NR*, where * represents an integer.

[0061] The term "non-aromatic heterocycle" or "non-aromatic heterocyclic" refers to a 3- to 15-membered, preferably 4- to 10-membered, saturated or partially unsaturated heterocyclic compound containing 1 to 4 heteroatoms selected from oxygen, nitrogen, and sulfur: monocyclic, bicyclic, or tricyclic heterocyclic compounds containing, in addition to the carbocyclic member, 1 to 3 nitrogen atoms and / or 1 oxygen atom or sulfur atom, or 1 or 2 oxygen atoms and / or sulfur atoms; if the ring contains more than one oxygen atom, these oxygen atoms are not directly adjacent; for example (but not limited to) oxoheterobutyl, azaheterobutyl, thioheterobutyl, tetrahydrofuranyl, tetrahydrothiopheneyl, 1-pyrrolidinyl, 2-pyrrolidinyl, 3-pyrrolidinyl, isoxazolyl, isothiazolyl, 1-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl -Pyrazolyl, oxazolyl, thiazolyl, 1-imidazolyl, 2-imidazolyl, 4-imidazolyl, 1,2,4-oxadiazolyl, 1,2,4-thiadiazolyl, 1,2,4-triazolyl-1-yl, 1,2,4-triazolyl-3-yl, 1,2,3-triazolyl, 1,3,4-oxadiazolyl-1,3,4-thiadiazolyl, 1,3,4-triazolyl, dihydrofuranyl, dihydrothiophenyl, pyrrolidinyl, isoxazolinyl, isothiazolinyl, dihydropyrazolyl, dihydrooxazolyl, dihydrothiazolyl, piperidinyl, pyrazinyl, morpholinyl, thiomorpholinyl, 1,3-dioxacyclohexane-5-yl, tetrahydropyranyl, tetrahydrothiophenyl, hexahydropyridazinyl, hexahydropyrimidinyl, piperazinyl and cycloserine. Unless otherwise expressly stated, this definition also applies to heterocyclic groups, such as heterocyclic alkyl groups, which are part of a complex substituent.

[0062] The term "heteroaryl" or "aromatic heterocyclic" refers to a 5- or 6-membered fully unsaturated monocyclic system containing 1 to 4 heteroatoms selected from oxygen, nitrogen, and sulfur; if the ring contains more than one oxygen atom, they are not directly adjacent; 5-membered heteroaryls containing 1 to 4 nitrogen atoms or 1 to 3 nitrogen atoms and 1 sulfur or oxygen atom: In addition to carbon atoms, 5-membered heteroaryls may also contain 1 to 4 nitrogen atoms or 1 to 3 nitrogen atoms and 1 sulfur or oxygen atom as ring members, such as (but not limited to) furanyl, thiophene, pyrrole, isoxazolyl, isothiazolyl, pyrazolyl, oxazolyl, thiazolyl, imidazole, 1,2,4-oxadiazolyl, 1,2,4-thiazolyl, 1,2,4-triazolyl, 1,3,4-oxadiazolyl, 1,3, 4-Thiadiazolyl, 1,3,4-triazolyl, tetrazolyl; nitrogen-bonded 5-membered heteroaryl containing 1 to 4 nitrogen atoms, or benzo-fused nitrogen-bonded 5-membered heteroaryl containing 1 to 3 nitrogen atoms: In addition to carbon atoms, the 5-membered heteroaryl may contain 1 to 4 nitrogen atoms or 1 to 3 nitrogen atoms as ring members, wherein two adjacent carbon ring members or one nitrogen atom and one adjacent carbon ring member can be bridged by but-1,3-diene-1,4-diyl, wherein one or two carbon atoms can be replaced by nitrogen atoms, and these rings are connected to the backbone through one of the nitrogen ring members, such as (but not limited to) 1-pyrroleyl, 1-pyrazolyl, 1,2,4-triazol-1-yl, 1-imidazolyl, 1,2,3-triazol-1-yl and 1,3,4-triazol-1-yl.

[0063] Six-membered heteroaryl groups containing 1 to 4 nitrogen atoms: Six-membered heteroaryl groups containing 1 to 3 nitrogen atoms as ring members (excluding carbon atoms), such as (but not limited to) 2-pyridyl, 3-pyridyl, 4-pyridyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl, 1,2,4-triazin-3-yl, and 1,2,4,5-tetraazin-3-yl; containing 1 to 3 nitrogen atoms or 1 nitrogen atom and 1 oxygen atom or sulfur atom. Benzofused 5-membered heteroaryl compounds: such as (but not limited to) indole-1-yl, indole-2-yl, indole-3-yl, indole-4-yl, indole-5-yl, indole-6-yl, indole-7-yl, benzimidazol-1-yl, benzimidazol-2-yl, benzimidazol-4-yl, benzimidazol-5-yl, indazole-1-yl, indazole-3-yl, indazole-4-yl, indazole-5-yl, indazole-6-yl, indazole-7-yl, indazole-2-yl, 1-benzofuran-2-yl, 1-benzofuran-3-yl, 1-benzofuran -4-yl, 1-benzofuran-5-yl, 1-benzofuran-6-yl, 1-benzofuran-7-yl, 1-benzothiophene-2-yl, 1-benzothiophene-3-yl, 1-benzothiophene-4-yl, 1-benzothiophene-5-yl, 1-benzothiophene-6-yl, 1-benzothiophene-7-yl, 1,3-benzothiazol-2-yl, 1,3-benzothiazol-4-yl, 1,3-benzothiazol-5-yl, 1,3-benzothiazol-6-yl, 1,3-benzothiazol-7-yl, 1,3-benzooxazol-2-yl, 1,3 -benzoxazol-4-yl, 1,3-benzoxazol-5-yl, 1,3-benzoxazol-6-yl and 1,3-benzoxazol-7-yl; benzo-fused 6-membered heteroaryl compounds containing 1 to 3 nitrogen atoms: for example (but not limited to) quinoline-2-yl, quinoline-3-yl, quinoline-4-yl, quinoline-5-yl, quinoline-6-yl, quinoline-7-yl, quinoline-8-yl, isoquinoline-1-yl, isoquinoline-3-yl, isoquinoline-4-yl, isoquinoline-5-yl, isoquinoline-6-yl, isoquinoline-7-yl and isoquinoline-8-yl.

[0064] As used herein, the term “heteroaryloxy-C1-C3-alkyl-” refers to a heteroaryl ring as defined above, which is connected by an oxygen atom to a C1-C3-alkylene radical as generally defined above.

[0065] Unless otherwise expressly stated, as used herein, the term "heterocyclic oxygen-C1-C3-alkyl" refers to a heterocyclic -OR a , where R a It is a C1-C3-alkyl group, and the definition of heterocycles is as described above.

[0066] The term “N-oxide” includes any compound of formula (I) that contains at least one tertiary nitrogen atom oxidized to an N-oxide moiety.

[0067] The term "plant" is understood herein to mean all plants and plant populations, including both desirable and unwanted wild plants or crops (including naturally occurring crops). Crops can be plants that can be obtained through conventional breeding and optimization methods or biotechnology and genetic engineering methods or a combination of these methods, including transgenic plants and plant varieties protected by and not protected by plant breeders' rights.

[0068] In this disclosure, the term "plant" includes living organisms such as trees, shrubs, herbs, grasses, ferns, and mosses, which typically grow somewhere, absorb water and necessary substances through their roots, and synthesize nutrients in their leaves through photosynthesis.

[0069] Examples of "plants" as used in this invention include, but are not limited to: crops such as wheat, rye, barley, triticale, oats, or rice; sugar beets, such as sugar beets or forage beets; fruits and fruit trees, such as pome, stone fruit, or soft fruit, such as apple, pear, plum, peach, apricot, cherry, strawberry, raspberry, blackberry, or currant; legumes, such as lentils, peas, alfalfa, or soybeans; oilseed plants, such as rapeseed, mustard, olive, sunflower, coconut, cocoa bean, castor oil plants, oil palm, peanut, or soybeans; cucurbits, such as pumpkin, cucumber, or melon; and fiber plants, such as cotton, flax, hemp, or yellow... Hemp; citrus fruits and citrus trees, such as oranges, lemons, grapefruits, or tangerines; any horticultural plants, vegetables, such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, cucurbits, or red bell peppers; camphor trees, such as avocados, cinnamon, or camphor; cucurbitaceae plants; oilseed plants; energy and raw material plants, such as cereals, corn, soybeans, other legumes, rapeseed, sugarcane, or oil palm; tobacco; nuts; coffee; tea; cocoa; bananas; chili peppers; vines (table grapes and grape juice vines); hops; turf; stevia (also known as Stevia); natural rubber plants or ornamental and forestry plants, such as flowers, shrubs, broadleaf trees, or evergreens, such as conifers; and plant propagation materials, such as the seeds and crop materials of these plants.

[0070] Preferably, the plants described in this invention include, but are not limited to, cereals, corn, rice, soybeans and other legumes, fruits and fruit trees, grapes, nuts and nut trees, citrus and citrus trees, any horticultural plants, cucurbitaceous plants, oilseed plants, tobacco, coffee, tea, cocoa, beets, sugarcane, cotton, potatoes, tomatoes, onions, peppers and vegetables, ornamental plants, any flowering plants and other plants for human and animal use.

[0071] The term "plant part" refers to all parts and organs of a plant, both above and below ground. In this disclosure, the term "plant part" includes, but is not limited to, cuttings, leaves, branches, tubers, flowers, seeds, shoots, roots (including taproot, lateral roots, root hairs, root tips, and root caps), rhizomes, cuttings, buds, fruits, fruiting bodies, bark, stems, buds, axillary buds, meristematic tissue, nodes, and internodes. The term "its location" includes the soil, the plant, or the environment surrounding the plant part, as well as the equipment or tools used before, during, or after sowing / planting the plant or plant part.

[0072] In this disclosure, the term "pest" includes, but is not limited to, fungi, oomycetes (heteroflagellates), bacteria, insects, and rodents.

[0073] Insecticides generally refer to chemical or biological agents (such as insecticidal active ingredients, compounds, compositions, viruses, bacteria, antimicrobial agents, or disinfectants) that, through their action, prevent, incapacitate, kill, or otherwise inhibit pests. Target pests include insects, plant pathogens, weeds, and microorganisms that damage property, cause nuisance, spread disease, or act as disease vectors. The term insecticide also includes plant growth regulators (used to alter the growth, flowering, or reproductive rate of plants), defoliants (causing leaves or other foliage to fall off the plant, usually to facilitate harvesting), desiccants (promoting the drying of living tissue, such as removing unwanted plant tops), plant activators (activating plant physiological functions to defend against certain pests), safeners (reducing the unwanted herbicidal effect of insecticides on crops), and plant growth promoters (affecting plant physiological functions to increase plant growth, biomass, yield, or any other quality indicator of crop harvestability).

[0074] The term "effective insecticidal dose" refers to the amount of a composition or compound of formula (I) and mixtures thereof used that is sufficient to control harmful pests or protective materials on cultivated plants without causing substantial damage to the treated plants. This dose can vary widely and depends on a variety of factors, such as the species of animal pests to be controlled, the cultivated plants or materials being treated, climatic conditions, and the specific mixture used.

[0075] The term “effective fungicide amount” refers to the amount of a composition or compound of formula (I) used that is sufficient to control harmful fungi on cultivated plants or to protect harvested or stored products or materials without causing material damage to the treated plants, treated stored products or harvests or treated materials.

[0076] As used herein, “LG” refers to a leaving group. The compounds disclosed herein may exist in pure form or as mixtures of different isomers (e.g., stereoisomers or structural isomers). Various stereoisomers include enantiomers, diastereomers, chiral isomers, trans-blocking isomers, conformational isomers, rotational isomers, tautomers, optical isomers, polymorphs, and geometric isomers. Any desired mixture of these isomers is within the scope of the claims of this disclosure. Those skilled in the art will understand that when a stereoisomer is enriched relative to or separated from other isomers, it may exhibit higher activity and / or beneficial effects. Furthermore, those skilled in the art will understand processes, methods, or techniques for separating, enriching, and / or selectively preparing said isomers.

[0077] The compounds of the present invention can exist, where appropriate, as mixtures of different possible isomers, particularly mixtures of stereoisomers, such as E and Z, threo and erythro, and mixtures of optical isomers, and where appropriate, as mixtures of tautomers. The present invention discloses and claims protection for E- and Z-type isomers, threo and erythro isomers, optical isomers, any desired mixtures of these isomers, and possible tautomers.

[0078] This specification describes, with regard to non-limiting embodiments, the embodiments described herein, along with their various features and advantageous details. To avoid unnecessarily obscuring the embodiments herein, descriptions of well-known components and processing techniques have been omitted. The embodiments used herein are intended only to aid in understanding the specific implementations of the embodiments herein and to further enable those skilled in the art to practice the embodiments described herein. Therefore, these embodiments should not be construed as limiting the scope of the embodiments described herein.

[0079] The description of specific embodiments will fully reveal the general nature of the embodiments described herein, so that others can easily modify and / or adapt these specific embodiments of lung injury to various applications using existing knowledge without departing from the general concepts. Therefore, such modifications and adaptations should and are intended to be understood as being included within the equivalent meaning and scope of the disclosed embodiments. It should be understood that the wording or terminology used herein is for description only and not for limitation. Therefore, although embodiments have been described herein according to preferred embodiments, those skilled in the art will understand that the embodiments described herein can be implemented through modifications without departing from the spirit and scope of the embodiments described herein.

[0080] Although the invention will be described with respect to specific embodiments, such description should not be construed as limiting.

[0081] In each case, according to the invention, the compound of formula (I) includes its free form, hydrated form, any polymorph or salt thereof, for example, in the form of an agriculturally available product.

[0082] Salts of compounds of formula (I) are agriculturally acceptable and applicable salts. They can be prepared by conventional methods, for example, if a compound of formula (I) has a basic functional group, it can be prepared by reacting the compound with an acid of the corresponding anion.

[0083] Salts include, for example, acid addition salts such as hydrochlorides, sulfates, nitrates, phosphates, sulfonates, acetates, and benzoates.

[0084] The presence of one or more possible asymmetric carbon atoms in a compound of formula (I) means that the compound may exist as a chiral isomer, i.e., an enantiomer or a diastereomer. Furthermore, due to restricted single-bond rotation, a trans-isomer may also occur. Formula (I) is intended to encompass all possible isomeric forms and mixtures thereof.

[0085] This invention encompasses all possible isomers of the compound of formula (I) and mixtures thereof. Similarly, formula (I) is intended to encompass all possible tautomers (including lactam-imide tautomers and keto-enol tautomers). This invention covers all possible tautomer forms of the compound of formula (I).

[0086] It has been discovered that novel 1,2,4-oxadiazole compounds of formula (I) have excellent biological activity and can be used to protect plants from diseases caused by plant pathogenic fungi.

[0087] Compared with compounds reported in the literature, compounds of formula (I) have advantages in the following aspects: higher insecticidal and / or fungicidal activity, broader bioactivity spectrum, lower application rate, better toxicological or environmental characteristics, and stronger plant compatibility.

[0088] In view of the above objectives, the present invention provides a compound of formula (I), or a salt, stereoisomer, polymorph or N-oxide thereof.

[0089] (I) in, A 1 Selected from NR A1 Or O; where R A1 Selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C3-C6 cycloalkyl, and C3-C6 cycloalkyl-C1-C3 alkyl; R 1 Selected from hydrogen, halogens, C1-C3 alkyl groups, C1-C3 haloalkyl groups, and C3-C6 cycloalkyl groups; R 2 Selected from hydrogen, halogens, methyl, and methoxy groups; R 3 Selected from hydrogen, halogens, C1-C3 alkyl groups, and C1-C3 alkoxy groups; R 4 Selected from the following groups: hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-ynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C3-C6-halocycloalkyl, C1-C6-alkoxy, C2-C6-alkenoxy, C2-C 6-Alkynoyl, C1-C6-Haloalkoxy, C3-C6-Cycloalkoxy, C1-C6-alkylthio, C1-C6-Haloalkylthio, Cyano-C1-C6-alkyl-, C3-C6-Cycloalkyl-C1-C6-alkyl-, C3-C6-Cycloalkyl-C2-C6-Alkenyl-, C3-C6-Cycloalkyl-C2-C4-Alkyno-, C1-C6-Alkoxy-C1-C6-alkyl-, -(CHR 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -NR 8 CONR 8 R 9 -NR 8 SO2R 10 -(CHR) 3 ) 0-2 COR 9 -(CHR)3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 -CON=SO(R 12 )-R 13 -CONR 8 SO2R 10 , phenyl, phenyl-C1-C6-alkyl-, phenoxy-C1-C3-alkyl-, naphthyl, C5-C 12 Saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocycles with C1-C3-alkyl groups, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl groups, 5- or 6-membered heteroaryl-C1-C3-alkyl groups, 5- to 10-membered heteroaryl oxy-C1-C3-alkyl groups, and 9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl groups; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaromatic rings, and 8- to 10-membered bicyclic heteroaromatic rings contain 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b 1 to 4 substituents; R 5 Selected from H or C1-C3 alkyl groups; or, R 5 and R A1 The N atom attached to it together forms a 5-6 membered non-aromatic heterocycle, which contains 1, 2 or 3 heteroatoms independently selected from N, O, S, S(O) or SO2, wherein 1 to 2 carbon atoms on the heterocycle may be substituted by C=O or C=S; the 5-6 membered heterocycle is either unsubstituted or substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy or C1-C6 haloalkoxy. R 6 Selected from hydrogen or C1-C6 alkyl; R 6aThe alkyl group is selected from C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 alkoxy-C1-C3 alkyl, C1-C6 alkylthio-C1-C3 alkyl, C3-C6 cycloalkyl and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, trifluoromethyl, methoxy or ethoxy; R 7a Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-cycloalkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR 9a , benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, indene, phenylthio, C1-C6-haloalkylthio and C1-C6-alkylcarbonyl; wherein, the C3-C6 cycloalkyl, pyrazolyl, phenyl and phenylthio are not substituted, or are substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, ethyl, amino, trifluoromethyl, methoxy or ethoxy; R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered non-aromatic heterocycles containing 1, 2 or 3 heteroatoms (independently selected from N, O or S), C1-C6-alkylcarbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8a R 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a -(CHR) 3 ) 0-2 COR9a -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 CONR 8a R 9a -CON=SO(R 12a )-R 13a and -CONR 8a SO2R 10a Wherein, the phenyl, phenoxy, and heterocyclic compounds are either unsubstituted or substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy. R 8 Independently selected from hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl, phenyl, and C1-C6-alkoxy; R 9 The group is selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C6-alkyl, phenyl and 5-6 membered heteroaromatic rings; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different groups selected from methyl, methoxy or halogen; R 10 Selected from halogens, -OH, -N(R) 8 2. C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 11 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, benzyl, and phenyl; R 12 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 13 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 8a Selected from hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, and C1-C6 alkoxy; R 9aThe group is selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, pyridyl, and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different groups selected from methyl, methoxy, or halogen; R 10a Selected from halogens, OH, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C6 cycloalkyl-C1-C6 alkyl; R 11a Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl; R 12a Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl; R 13a It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0090] In one embodiment of the present invention, the compound of formula (I) is represented as the compound of formula (IA).

[0091]

[0092] (IA) Among them, R 1 R 2 R 3 R 4 and R 5 The definition is the same as that of the compound of formula (I) of this invention.

[0093] In another embodiment, the present invention provides a compound of formula (IA), wherein R 1 R 2 R 3 and R 4 The definition is the same as that of the compound of formula (I) of this invention, and R 5 It is a methyl group.

[0094] In yet another embodiment, the present invention provides a compound of formula (IA), wherein R... 1 Selected from hydrogen, halogen, or C1-C3 alkyl; R 2 Selected from hydrogen or methyl; R 3 Selected from hydrogen or C1-C3 alkyl; R 5 It is methyl, and R 4 The definition is the same as that of the compound of formula (I) of this invention.

[0095] In a preferred embodiment, the present invention provides a compound of formula (IA), wherein R 1 Selected from hydrogen, halogen, or C1-C3 alkyl, preferably, R 1 Selected from hydrogen, methyl, chlorine, or fluorine; R 2 Selected from hydrogen or methyl, preferably R 2 It is hydrogen; R 3 It is hydrogen, and R 4 Selected from: hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C3-C6-halocycloalkyl, C1-C6-alkoxy, C2-C6-alkenoxy, C2-C6- Acryloxy, C1-C6-haloalkoxy, C3-C6-cycloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, cyano-C1-C6-alkyl-, C3-C6-cycloalkyl-C1-C4-alkyl-, C3-C6-cycloalkyl-C2-C6-alkenyl-, C3-C6-cycloalkyl-C2-C4-alkynyl-, C1-C6-alkoxy-C1-C3-alkyl-, -(CHR 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -NR 8 CONR 8 R 9 -NR 8 SO2R 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0- 2NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 -CON=SO(R 12 )-R 13 -CONR 8 SO2R10 , phenyl, phenyl-C1-C6-alkyl-, phenoxy-C1-C3-alkyl-, naphthyl, C5-C 12 Saturated or partially unsaturated compounds include bicarbonyl or tricarbonyl rings, 5- or 6-membered heteroaromatic rings, 8-10-membered bicyclic heteroaromatic rings, 4-10-membered non-aromatic heterocycles, 4-10-membered non-aromatic heterocyclic alkyl-C1-C3-alkyl, 4-10-membered heterocyclic oxy-C1-C3-alkyl, 5- or 6-membered heteroaryl-C1-C3-alkyl, 5-10-membered heteroaryloxy-C1-C3-alkyl, and 9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl; wherein the 4-10-membered non-aromatic heterocycle, the 5- or 6-membered heteroaromatic ring, and the 8-10-membered bicyclic heteroaromatic ring each contain 1, 2, or 3 heteroatoms independently selected from N, O, or S. Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents. 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0096] In another preferred embodiment, the present invention provides a compound of formula (IA), wherein R 1 Selected from hydrogen, halogen, or C1-C3 alkyl, preferably R 1 Selected from hydrogen, methyl, chlorine, or fluorine; R 2 Selected from hydrogen or methyl, preferably R 2 It is hydrogen. R 3 It is hydrogen, and R 4 Selected from hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C1-C6-alkoxy, C1-C6-alkoxy-C1-C3-alkyl, C1-C6-haloalkoxy, C3-C6-cycloalkyl-C1-C4-alkyl, -(CHR) 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 COR 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0- 2NHCOOR 6 , phenyl, phenyl-C1-C6-alkyl, phenoxy-C1-C3-alkyl, naphthyl, C5-C 12 Saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocyclic rings, 4- to 10-membered non-aromatic heterocyclic -C1-C3-alkyl, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl, 5- or 6-membered heteroaryl -C1-C3-alkyl, 5- to 10-membered heteroaryloxy-C1-C3-alkyl, and 9- or 10-membered bicyclic heteroaryl -C1-C3-alkyl; wherein the 4- to 10-membered non-aromatic heterocyclic rings, the 5- or 6-membered heteroaromatic rings, and the 8- to 10-membered bicyclic heteroaromatic rings comprise 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0097] In another preferred embodiment, the present invention provides a compound of formula (IA), wherein R 7a Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-cycloalkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR 9a , benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, phenylthio, -C1-C6-haloalkylthio, C1-C6-alkylcarbonyl and 4-6 membered non-aromatic heterocycles; wherein the C3-C6 cycloalkyl, pyrazolyl, phenyl and phenylthio are unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, ethyl, amino, trifluoromethyl, methoxy or ethoxy; R 7b Selected from the following groups: halogen, cyano, NO2, -OH, -N(R) 82. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered non-aromatic heterocycles (containing 1, 2 or 3 independently selected from N, O or S(O)). 0-2 heteroatoms), C1-C6-alkyl carbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8a R 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a -(CHR) 3 ) 0-2 COR 9a -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 CONR 8a R 9a -CON=SO(R 12a )-R 13a and -CONR 8a SO2R 10a Wherein, the phenyl, phenoxy, and heterocyclic compounds are either unsubstituted or substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy.

[0098] In another preferred embodiment, the present invention provides a compound of formula (IA), wherein R 7a Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-cycloalkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR9a , benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, phenylthio, -C1-C6-haloalkylthio and C1-C6-alkylcarbonyl; wherein, the C3-C6 cycloalkyl (preferably cyclopropyl), pyrazolyl, phenyl and phenylthio are unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, amino, trifluoromethyl, methoxy or ethoxy; R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered non-aromatic heterocycles (containing 1, 2 or 3 heteroatoms independently selected from N, O or S), C1-C6-alkylcarbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8a R 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a -(CHR) 3 ) 0-2 COR 9a -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 CONR 8a R 9a -CON=SO(R 12a )-R 13a and -CONR 8a SO2R 10a Wherein, the phenyl, phenoxy, and heterocyclic compounds are either unsubstituted or substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy.

[0099] In one embodiment of the present invention, the compound of formula (I) is represented as the compound of formula (IB).

[0100]

[0101] (IB) Among them, R A1 Selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C1-C6-alkoxy, C3-C6-cycloalkyl, and C3-C6-cycloalkyl-C1-C3-alkyl; R 1 R 2 R 3 R 4 and R 5 The definition is the same as that in the compound of formula (I).

[0102] In another embodiment of the invention, the compound of formula (IB) is represented as the compound of formula (I-B1).

[0103]

[0104] (I-B1) Among them, R 1 R 2 R 3 R 4 and R 5 The definition is the same as that in the compound of formula (I).

[0105] The following list provides information on substituent A in compounds of formula (I) of this invention. 1 R 1 R 2 R 3 R 4 R 5 R 6 R 6a R 7a R 7b R 8 R 8a R 9 R 9a R 10 R 10a R 11 R 11a R 12 R 12a R 13 and R 13a Definitions (including preferred definitions) of substituents. For any of these substituents, any of the following definitions may be combined with the definitions of any other substituents given below or in other parts of this document.

[0106] In one embodiment of the present invention, A 1 Selected from NR A1Or O.

[0107] In another embodiment of the invention, A 1 For NR A1 , where R A1 It is selected from hydrogen, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C3 alkyl.

[0108] In a preferred embodiment of the present invention, A 1 It is O.

[0109] In one embodiment of the present invention, R 1 It is selected from hydrogen, halogen, C1-C3 alkyl, C1-C3 haloalkyl and C3-C6 cycloalkyl.

[0110] In another embodiment of the invention, R 1 It is selected from hydrogen, halogens and C1-C3 alkyl groups.

[0111] In yet another embodiment of the invention, R 1 It is selected from hydrogen, halogen, methyl, ethyl and propyl.

[0112] In a preferred embodiment of the present invention, R 1 It is selected from hydrogen, fluorine, chlorine, methyl, ethyl and propyl.

[0113] In a more preferred embodiment of the present invention, R 1 It is selected from hydrogen, fluorine, chlorine, methyl and ethyl.

[0114] In a preferred embodiment of the present invention, R 1 It is a methyl group.

[0115] In one embodiment of the present invention, R 2 It is selected from hydrogen, halogen, methyl and methoxy.

[0116] In another embodiment of the invention, R 2 Selected from hydrogen, halogens, and methyl.

[0117] In a preferred embodiment of the present invention, R 2 Selected from hydrogen, fluorine, chlorine or methyl.

[0118] In a more preferred embodiment of the present invention, R 2 It is hydrogen.

[0119] In one embodiment of the present invention, R 3 It is selected from hydrogen, halogen, C1-C3 alkyl and C1-C3 alkoxy.

[0120] In a preferred embodiment of the present invention, R 3 It is selected from hydrogen, halogen or C1-C3 alkyl.

[0121] In a more preferred embodiment of the present invention, R 3 It is hydrogen.

[0122] In one embodiment of the present invention, R 4 Selected from hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C3-C6-halocycloalkyl, C1-C6-alkoxy, C2-C6-alkenoxy, C2-C6- Acryloxy, C1-C6-haloalkoxy, C3-C6-cycloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, cyano-C1-C6-alkyl-, C3-C6-cycloalkyl-C1-C6-alkyl-, C3-C6-cycloalkyl-C2-C6-alkenyl-, C3-C6-cycloalkyl-C2-C4-alkynyl-, C1-C6-alkoxy-C1-C6-alkyl-, -(CHR 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -NR 8 CONR 8 R 9 -NR 8 SO2R 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0- 2NHCOOR 6 -CON=SO(R 12 )-R 13 -CONR 8 SO2R 10, phenyl, phenyl-C1-C6-alkyl-, phenoxy-C1-C3-alkyl, naphthyl, C5-C 12 Saturated or partially unsaturated compounds include bicyclic or tricyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocycles with C1-C3-alkyl groups, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl groups, 5- or 6-membered heteroaryl-C1-C3-alkyl groups, 5- to 10-membered heteroaryloxy-C1-C3-alkyl groups, and 9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl groups; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaromatic rings, and 8- to 10-membered bicyclic heteroaromatic rings contain 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents. 4 The cyclic groups are not substituted or are independently selected from R 7b 1 to 4 substituents; In another embodiment of the invention, R 4 Selected from hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C6-cycloalkoxy, C1-C6-alkylthio, cyano-C1-C6-alkyl-, C3-C6-cycloalkyl-C1-C4-alkyl-, C1-C6-alkoxy-C1-C3-alkyl-, -(CHR) 3 ) 0- 2C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -NR 8 CONR 8 R 9 -NR 8 SO2R 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 , phenyl, phenyl-C1-C6-alkyl, phenoxy-C1-C3-alkyl, naphthyl, C5-C 12 The compounds include saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaryl rings, 8- to 10-membered bicyclic heteroaryl rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocyclic-C1-C3-alkyl groups, 4- to 10-membered non-aromatic heterocyclic-C1-C3-alkyl groups, 5- or 6-membered heteroaryl-C1-C3-alkyl groups, 5- to 10-membered heteroaryloxy-C1-C3-alkyl groups, and 9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl groups; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaryl rings, and 8- to 10-membered bicyclic heteroaryl rings comprise 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0123] In a preferred embodiment of the present invention, R 4 Selected from hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C6-cycloalkoxy, C1-C6-alkylthio, C3-C6-cycloalkyl-C1-C4-alkyl, C1-C6-alkoxy-C1-C3-alkyl, -(CHR) 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR6 -(CHR) 3 ) 0-2 NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 , phenyl, phenyl-C1-C6-alkyl, phenoxy-C1-C3-alkyl, naphthyl, C5-C 12 The compounds include saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocyclic -C1-C3-alkyl, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl, 5- or 6-membered heteroaryl -C1-C3-alkyl, 5- to 10-membered heteroaryloxy-C1-C3-alkyl, and 9- or 10-membered bicyclic heteroaromatic -C1-C3-alkyl; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaromatic rings, and 8- to 10-membered bicyclic heteroaromatic rings comprise 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0124] In another preferred embodiment of the invention, R 4 Selected from phenyl or phenyl-C1-C6-alkyl. Wherein, R... 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents. 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0125] In another preferred embodiment of the invention, R 4 The ring is selected from 5- or 6-membered heteroaromatic rings, 5- or 6-membered heteroaromatic-C1-C3-alkyl rings, 8- to 10-membered bicyclic heteroaromatic rings, 9- or 10-membered bicyclic heteroaromatic-C1-C3-alkyl rings, 4- to 10-membered non-aromatic heterocyclic-C1-C3-alkyl rings, or 4- to 10-membered non-aromatic heterocycles; wherein the ring contains 1, 2, or 3 heteroatoms, which are independently selected from N, O, or S(O). 0-2 Preferably, N, O, or S. Wherein, R... 4The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 3 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b The 1 to 4 substituents are substituted.

[0126] In another preferred embodiment of the invention, R 4 Selected from 5- or 6-membered heterocyclic aromatic rings, 9- or 10-membered bicyclic heterocyclic aromatic rings, or 4- to 10-membered non-aromatic heterocyclic rings; wherein R 4 Not replaced or independently selected from R 7b The 1 to 3 substituents are substituted.

[0127] In another preferred embodiment of the invention, R 4 Selected from C1-C6 alkyl or C1-C6 haloalkyl; wherein the C1-C6 alkyl or C1-C6 haloalkyl is not substituted or is independently selected from R 7a The 1 to 3 substituents are substituted.

[0128] In another preferred embodiment of the invention, R 4 It is a C3-C6 cycloalkyl group; wherein the C3-C6 cycloalkyl group is not substituted or is independently selected from R 7b The 1 to 3 substituents are substituted.

[0129] In one embodiment of the present invention, R 7a Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-cycloalkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR 9a The compounds include benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, phenylthio, -C1-C6-haloalkylthio, C1-C6-alkylcarbonyl, and 4-6 membered heterocyclic groups; wherein the C3-C6 cycloalkyl, pyrazolyl, phenyl, and phenylthio groups are not substituted, or are substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, ethyl, amino, trifluoromethyl, methoxy, or ethoxy.

[0130] In another embodiment of the invention, R 7a Selected from halogens, cyano groups, -OH groups, and -N(R) groups. 82. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O) 2- C1-C6-alkyl, -SR 9a , benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, -C1-C6-haloalkylthio, C1-C6-alkylcarbonyl and 4-6 membered heterocyclic groups; wherein the C3-C6 cycloalkyl, pyrazolyl, phenyl and phenylthio groups are not substituted, or are substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, amino, trifluoromethyl, methoxy or ethoxy.

[0131] In a preferred embodiment of the present invention, R 7a Selected from halogens, cyano groups, -OH groups, and -N(R) groups. 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR 9a The compounds include benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, and 4-6 membered heterocyclic groups; wherein the C3-C6-cycloalkyl (preferably cyclopropyl), pyrazolyl, phenyl, and phenylthio groups are not substituted, or are substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, amino, trifluoromethyl, methoxy, or ethoxy.

[0132] In one embodiment of the present invention, R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered heterocycles containing 1, 2 or 3 heteroatoms independently selected from N, O or S, C1-C6-alkylcarbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8aR 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a -(CHR) 3 ) 0-2 COR 9a -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 CONR 8a R 9a -CON=SO(R 12a )-R 13a and -CONR 8a SO2R 10a Wherein, the phenyl, phenoxy, and heterocyclic compounds are not substituted, or are substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy.

[0133] In another embodiment of the invention, R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered heterocycles containing 1, 2 or 3 heteroatoms independently selected from N, O or S, C1-C6-alkylcarbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8a R 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a and -(CHR) 3 ) 0-2 COR 9aThe phenyl, phenoxy, and heterocyclic compounds are either unsubstituted or substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy.

[0134] In a preferred embodiment of the present invention, R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, phenyl, phenoxy, 4-6 membered heterocycles containing 1, 2 or 3 heteroatoms independently selected from N, O or S, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a and -(CHR) 3 ) 0-2 COR 9a Wherein, the phenyl, phenoxy, and heterocyclic compounds are not substituted, or are substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, or methoxy.

[0135] In one embodiment of the present invention, R 5 Selected from hydrogen or C1-C3 alkyl.

[0136] In another embodiment of the invention, R 5 It is a C1-C3 alkyl group.

[0137] In a preferred embodiment of the present invention, R 5 It is a C1-C3 alkyl group selected from methyl, ethyl, propyl or isopropyl.

[0138] In a more preferred embodiment of the present invention, R 5 It is a methyl group.

[0139] In one embodiment of the present invention, R 6 Selected from H or C1-C6 alkyl groups.

[0140] In another embodiment of the invention, R 6 For H.

[0141] In yet another embodiment of the invention, R 6 It is a C1-C6 alkyl group.

[0142] In a preferred embodiment of the present invention, R 6 It is a C1-C4 alkyl group.

[0143] In one embodiment of the present invention, R 6a The alkyl group is selected from C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 alkoxy-C1-C3 alkyl, C1-C6 alkylthio-C1-C3 alkyl, C3-C6 cycloalkyl and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, trifluoromethyl, methoxy or ethoxy.

[0144] In another embodiment of the invention, R 6a The alkyl group is selected from C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy-C1-C3 alkyl, C1-C6 alkylthio-C1-C3 alkyl, C3-C6 cycloalkyl and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, trifluoromethyl, methoxy or ethoxy.

[0145] In a preferred embodiment of the present invention, R 6a The alkyl group is selected from C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy-C1-C3 alkyl, C1-C4 alkylthio-C1-C3 alkyl, C3-C6 cycloalkyl, and phenyl. The phenyl group is either unsubstituted or substituted with one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, trifluoromethyl, methoxy, or ethoxy.

[0146] In one embodiment of the present invention, R 8 Independently selected from hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, phenyl, and C1-C6 alkoxy; In another embodiment of the invention, R 8 Independently selected from hydrogen, C1-C4 alkyl, C3-C6 cycloalkyl, phenyl, and C1-C4 alkoxy; In a preferred embodiment of the present invention, R 8 It is independently selected from hydrogen, C1-C4 alkyl and phenyl.

[0147] In one embodiment of the present invention, R 9 The group is selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 heteroaryl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from methyl, methoxy or halogen.

[0148] In another embodiment of the invention, R9 The group is selected from hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C3 alkyl, phenyl and 5-6 heteroaryl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from methyl, methoxy or halogen.

[0149] In a preferred embodiment of the present invention, R 9 The group is selected from hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl and phenyl; wherein the phenyl group is unsubstituted or substituted by one to three identical or different groups selected from methyl, methoxy or halogen.

[0150] In one embodiment of the present invention, R 10 Selected from halogens, -OH, -N(R) 8 2. C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 heteroaryl groups.

[0151] In another embodiment of the invention, R 10 Selected from halogens, -OH, -N(R) 8 2. C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C6 cycloalkyl-C1-C3 alkyl, phenyl and 5-6 heteroaryl.

[0152] In one embodiment of the present invention, R 11 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, benzyl and phenyl.

[0153] In another embodiment of the invention, R 11 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, benzyl and phenyl.

[0154] In yet another embodiment of the invention, R 11 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, benzyl and phenyl.

[0155] In one embodiment of the present invention, R 12 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 heteroaryl.

[0156] In another embodiment of the invention, R 12 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0157] In another embodiment of the invention, R 12 It is selected from C1-C6 alkyl, C1-C6 haloalkyl and C3-C6 cycloalkyl.

[0158] In one embodiment of the present invention, R 13 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 heteroaryl.

[0159] In another embodiment of the invention, R 13 It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0160] In yet another embodiment of the invention, R 13 It is selected from C1-C6 alkyl, C1-C6 haloalkyl and C3-C6 cycloalkyl.

[0161] In one embodiment of the present invention, R 8a It is selected from hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl and C1-C6-alkoxy.

[0162] In another embodiment of the invention, R 8a It is selected from hydrogen, C1-C3 alkyl, C3-C6 cycloalkyl and C1-C3 alkoxy.

[0163] In yet another embodiment of the invention, R 8a It is selected from hydrogen, C1-C3 alkyl and C1-C3 alkoxy.

[0164] In one embodiment of the present invention, R 9a The group is selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, pyridyl, and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from methyl, methoxy, or halogen.

[0165] In another embodiment of the invention, R 9a The group is selected from hydrogen, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C3 alkyl, pyridyl, and phenyl; wherein the phenyl group is unsubstituted or substituted by one to three identical or different groups selected from methyl, methoxy, or halogen.

[0166] In yet another embodiment of the invention, R 9aThe alkyl group is selected from C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl-C1-C3 alkyl, pyridyl, and phenyl; wherein the phenyl group is unsubstituted or substituted by one to three identical or different substituents selected from methyl, methoxy, or halogen.

[0167] In one embodiment of the present invention, R 10a It is selected from halogens, -OH, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C6 cycloalkyl-C1-C6 alkyl.

[0168] In another embodiment of the invention, R 10a It is selected from halogens, -OH, C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl and C6 cycloalkyl-C1-C3 alkyl.

[0169] In yet another embodiment of the invention, R 10a It is selected from halogens, -OH, C1-C4 alkyl groups and C1-C4 haloalkyl groups.

[0170] In one embodiment of the present invention, R 11a It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0171] In another embodiment of the invention, R 11a It is selected from C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C4 alkyl.

[0172] In a preferred embodiment of the present invention, R 11a It is a C1-C4 alkyl group, selected from methyl, ethyl, propyl, isopropyl or butyl.

[0173] In one embodiment of the present invention, R 12a It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0174] In another embodiment of the invention, R 12a It is selected from C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C3 alkyl.

[0175] In another embodiment of the invention, R 12a Selected from C1-C4 alkyl and C1-C4 haloalkyl.

[0176] In one embodiment of the present invention, R 13aIt is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

[0177] In another embodiment of the invention, R 13a It is selected from C1-C4 alkyl, C1-C4 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C3 alkyl.

[0178] In yet another embodiment of the invention, R 13a Selected from C1-C4 alkyl and C1-C4 haloalkyl.

[0179] In one embodiment of the present invention, R 5 and R A1 The N atom attached thereto forms a 5-6 membered non-aromatic heterocycle, which may contain optional other heteroatoms selected from N, O, S, S(O) or SO2, wherein 1 to 2 carbon atoms may be substituted by C=O or C=S; the 5-6 membered heterocycle is either unsubstituted or substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy or C1-C6 haloalkoxy.

[0180] In another embodiment of the invention, R 5 and R A1 The N atom attached thereto forms a 5-6 membered non-aromatic heterocycle, which may contain optional other heteroatoms selected from N, O, S, S(O) or SO2; the 5-6 membered heterocycle is either unsubstituted or substituted by 1 to 3 substituents independently selected from halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy.

[0181] In a preferred embodiment of the present invention, R 5 and R A1 The N atom attached thereto forms a 6-membered non-aromatic heterocycle, which may contain optional other heteroatoms selected from N, O or S; the 6-membered heterocycle is either unsubstituted or substituted by one or two substituents independently selected from halogen, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy or C1-C4 haloalkoxy.

[0182] In a preferred embodiment of the present invention, R 5 and R A1 The N atom attached thereto forms a six-membered non-aromatic heterocycle, which may contain optional other heteroatoms selected from N or O; the six-membered heterocycle is either unsubstituted or substituted by one or two substituents independently selected from halogens or C1-C4 alkyl groups.

[0183] In one embodiment of the invention, R4 The aliphatic groups are not substituted or are independently selected from R 7a The 1 to 4 substituents are substituted, and R 4 The cyclic groups are not substituted or are independently selected from R 7b Substitution of 1 to 4 substituents, for example, when R 4 When it is a C1-C8 alkyl (aliphatic group), then the C1-C8 alkyl group is either unsubstituted or independently selected from R. 7a Substitution of 1 to 4 substituents. Similarly, when R 4 When it is a phenyl group (cyclic group), the phenyl group is either unsubstituted or independently selected from R. 7b Substitution of 1 to 4 substituents. Similarly, when R 4 When it is phenyl-C1-C6-alkyl, then the C1-C6-alkyl (aliphatic group) of the phenyl-C1-C6-alkyl group is not substituted or is independently selected from R. 7a One to four substituents are substituted; the phenyl group of the phenyl-C1-C6-alkyl group is unsubstituted or independently selected from R. 7a Substitution of 1 to 4 substituents. The examples provided herein are for illustrative purposes only. Unless otherwise expressly stated, this substitution pattern applies to R. 4 All groups.

[0184] In one embodiment, the present invention provides a method for preparing a compound of formula (I).

[0185] In one embodiment, the compound of formula (I) may be a mixture of E and Z isomers.

[0186] In another embodiment, the compound of formula (I) is the Z isomer.

[0187] Compounds of formula (I) (including all their stereoisomers, N-oxides, and their salts) typically exist in multiple forms; therefore, formula (I) encompasses all crystalline and amorphous forms of the compounds represented by formula (I). The term "polymorph" refers to a specific crystalline form of a compound that can crystallize into different crystalline forms in which the arrangement and / or conformation of molecules in the crystal lattice differs. Although polymorphs may have the same chemical composition, their compositions may differ due to the presence or absence of co-crystallization water or other molecules, and the binding strength of these molecules in the crystal lattice may vary. Polymorphs may differ in chemical, physical, and biological properties such as crystal shape, density, hardness, color, chemical stability, melting point, hygroscopicity, suspension, dissolution rate, and bioavailability. Those skilled in the art will understand that a certain polymorph of a compound represented by formula (I) may exhibit beneficial effects (e.g., better suitability for the preparation of useful formulations, superior biological properties) relative to another polymorph or mixture of polymorphs of a compound represented by formula (I). The preparation and separation of specific polymorphs of the compound shown in formula (I) can be achieved by methods known to those skilled in the art, such as crystallization using selected solvents and temperatures.

[0188] In one embodiment, the present invention provides a compound of formula (Z);

[0189] Among them, R 1 R 2 R 3 A 1 and R 5 As defined above, This indicates a point that connects to the rest of the molecule.

[0190] In one embodiment, the present invention provides a method for preparing a compound of formula (I), wherein A 1 For oxygen, the method includes the following steps: a) In the presence of a suitable solvent, react compound (II) with compound (VIII) to obtain compound (I), as shown in the following scheme: ; Alternatively, in the presence of a suitable coupling agent, a suitable base, and a suitable solvent, compound (II) can be reacted with compound (IX) to obtain compound (I), as shown in the following scheme: ; or, In the presence of a suitable base and a suitable solvent, compound (II) is reacted with compound (X) to obtain compound (I), as shown in the following scheme: ; b) Optionally, in the presence of a suitable base and a suitable solvent, the compound of formula (III) is reacted with an aqueous solution of hydroxylamine or hydroxylamine hydrochloride to give the compound of formula (II), as shown in the following scheme: ; c) In the presence of a suitable base, a suitable metal catalyst, and a suitable solvent, the compound of formula (IV) is reacted with a cyanide salt via a metal-catalyzed reaction to obtain the compound of formula (III), as shown in the following scheme: .

[0191] In one embodiment, the present invention provides a method for preparing a compound of formula (IV), wherein A 1 For oxygen, the method includes the following steps: a) In the presence of a suitable base, a suitable formylating agent and a suitable solvent, the compound of formula (V) is reacted to give the compound of formula (VA), and then methylated in the presence of a suitable base, a suitable reagent and a suitable solvent to give the compound of formula (IV).

[0192] ; or In the presence of an acid and a suitable solvent, the compound of formula (V) is reacted with an orthoester to give the compound of formula (IV);

[0193] b) In the presence of a suitable base and a suitable solvent, the compound of formula (VI) is reacted with the compound of formula (VII) to give the compound of formula (V).

[0194]

[0195] Where LG is halogen, A 1 For oxygen, R 1 R 2 R 3 R 4 and R 5 The definition is given above.

[0196] In one embodiment, the present invention provides a method for preparing an IB compound, the method comprising the following steps: a) React compound (I) with compound (XI-A) in a suitable solvent and at a suitable temperature to give compound (IB):

[0197] Among them, R 1R 2 R 3 R 4 R A1 and R 5 The definition is given above.

[0198] In one embodiment, the present invention provides a method for preparing a compound of formula (I-B1), the method comprising the following steps: a) React compound (I) with compound (XI) in a suitable solvent and at a suitable temperature to obtain compound (I-B1):

[0199] Among them, R 1 R 2 R 3 R 4 and R 5 The definition is given above.

[0200] The compounds of formula (I) and / or those defined in Table 1 can be prepared using a variety of known methods, as detailed in the scheme. The preparation methods of the compounds of the present invention are shown in the following scheme, and unless otherwise stated, the definitions of the variables are the same as those for the compounds of formula (I) above.

[0201] General synthesis scheme Option 1

[0202] Compound (I) can be prepared from compound (II) in the presence of acetic anhydride or acetyl chloride. Preferred solvents for this conversion reaction are tetrahydrofuran, acetonitrile, etc. The preferred reaction temperature for this conversion reaction is 20°C to 50°C. Such conversion reactions have been reported in the literature, for example, see [link to relevant documentation]. Tetrahedron Lett. 2001, 42 , 1441-1443 and Synthesis 2001, 16 , 2427-2430, the reaction formula is shown in Scheme 1.

[0203] Option 2

[0204] Alternatively, in the presence of a substituted carboxylic acid, compound (II) can also be synthesized into compound (I). The following synthetic route involves the use of a coupling agent (e.g., O -benzotriazole-1-yl- N,N,N',N'In the presence of tetramethylurea tetrafluoroborate (TBTU), 1-hydroxybenzotriazole hydrate (HOBt), and propylphosphonic anhydride, an amide oxime (Formula II) is coupled to a carboxylic acid (IX), followed by in-situ thermal cyclization, as shown in Scheme 2. The base used in the above transformation is, for example, diisopropylethylamine, triethylamine, etc. Preferred solvents for this reaction are toluene, dichloromethane, dimethylformamide, ethyl acetate, tetrahydrofuran, etc. Such transformations have been reported in the literature, for example, see [link to relevant documentation]. Org. Biomol. Chem. 2021, 19, 10611-10616.

[0205] Option 3

[0206] Furthermore, compounds of formula (I) can be prepared from compounds of formula (II) in the presence of a substituted acyl chloride of formula (X). The following synthetic route involves coupling an amidoxime (formula II) with an acyl chloride in the presence of an organic or inorganic base (e.g., pyridinetriethylamine, potassium carbonate, etc.), followed by an in-situ thermal cyclization reaction, as shown in Scheme 3. Suitable solvents for the reaction include, for example, toluene, xylene, dichloroethane, or dioxane. Such transformations have been reported in the literature, see, for example, [link to relevant documentation]. Org. Lett. 2017 ,19, 2885-2888.

[0207] Option 4

[0208] The amide oxime compounds of formula (II) can be prepared by reacting nitrile compounds of formula (III) with aqueous solutions or hydrochlorides of hydroxylamine. The reaction can optionally be carried out in the presence of a base, such as an organic base (e.g., triethylamine or diisopropylethylamine), at a temperature of 0°C to 25°C, as shown in Scheme 4. Option 5

[0209] Nitrile compounds of formula (III) can be prepared from compounds of formula (IV) in the presence of cyanide salts (e.g., copper cyanide, potassium ferrocyanide), optionally in the presence of organic or inorganic bases (e.g., potassium carbonate, pyridine, sodium carbonate, etc.), wherein LG is a halogen, such as fluorine or chlorine. Compounds of formula (III) can also be prepared from compounds of formula (IV), wherein LG is a halogen, such as bromine or iodine. The reaction can be carried out in the presence of cyanide salts (e.g., copper cyanide, zinc cyanide, etc.) via metal catalysis (e.g., palladium catalyst), as shown in Scheme 5. Such transformations have been reported in the literature, for example, see [link to relevant documentation]. Synth. Commun. 1994, 24, 887-890. In addition, as in the literature... J. Org. Chem. 2018, 83As described in 4922-4931, such conversion can also be achieved by using a non-toxic cyanide source (e.g., potassium ferrocyanide (K4[Fe(CN)6))) for metal-catalyzed cyanidation reaction.

[0210] Option 6

[0211] Compound (IV) can be prepared from compound (V) by treatment with a base (e.g., sodium methoxide, sodium hydride) and a formylating agent (e.g., methyl formate) to generate compound (VA), followed by methylation with a reagent (e.g., dimethyl sulfate) in the presence of a base (e.g., potassium carbonate). Alternatively, compound (IV) can be prepared directly from compound (V) by treatment with an orthoester (e.g., HC(OMe)3) in a suitable solvent (e.g., methanol), optionally in the presence of an acid (e.g., sulfuric acid or hydrochloric acid), as shown in Scheme 6. This transformation has been reported in the literature, see, for example, [link to relevant documentation]. J. Agric. Food Chem. 2007 , 55 ,5697-5700, Molecules 2010, 15, 9024-9034 and Org. Process Res. Dev. 2015, 19 , 639-645.

[0212] Option 7

[0213] Compound (V) is prepared by the following method: in an organic solvent (e.g., N,N -dimethylformamide or N In methylpyrrolidone, it is prepared from compound (VI) by treatment with an organic or inorganic base and a compound of formula (VII), as shown in scheme 7. Such transformations have been reported in the literature, for example, see [link to relevant documentation]. Eur. JOC, 2015 , 2197-2204. Compounds of formula (VII) are commercially available or can be easily prepared from commercially available compounds by conversion of standard functional groups.

[0214] Option 8

[0215] Compounds of formula (I-B1) can be prepared by reacting a compound of formula (I) with an amine of formula (XI) in a suitable solvent (e.g., water, tetrahydrofuran, dioxane, etc.) at a temperature ranging from 0°C to 25°C, as shown in Scheme 8. Such transformations have been reported in the literature, for example, see [link to relevant documentation]. Synth. Commun. 1982, 12 , 989-993; Nat. Commun. 2021, 12, 5964 and WO9907665A1.

[0216] In one embodiment, the compound of formula (I) of the present invention may have a variety of beneficial effects, including, in particular, having a high level of bioactivity in protecting plants from harmful organisms and plant pathogenic fungi, or having excellent properties when used as an active ingredient in pesticides (e.g., higher bioactivity, excellent activity spectrum, higher safety (including improved crop tolerance), improved physicochemical properties, or improved biodegradability).

[0217] In one embodiment, the present invention relates to an agricultural chemical composition comprising a compound of formula (I), its salt, stereoisomer, polymorph or N-oxide, optionally one or more other active ingredients, and comprising an adjuvant, such as an inert carrier or any other essential ingredient, such as a surfactant, additive, solid diluent or liquid diluent.

[0218] In another embodiment, the present invention relates to an agricultural chemical composition comprising an effective fungicidal amount of a compound of formula (I), the amount of which can vary over a wide range and depends on various factors such as the species of fungus to be controlled, the cultivated plants being treated, the stored products, the harvested or raw materials, climatic conditions, and the specific compound of formula (I) used.

[0219] The present invention also relates to an agricultural chemical composition comprising an adjuvant and at least one compound of formula (I).

[0220] Compounds of formula (I) can be used in their unmodified form or preferably in combination with adjuvants commonly used in the formulation field. For this purpose, they can be readily formulated into known dual-package products, such as powders (DS) for dry seed treatment, emulsions (ES) for seed treatment, flow concentrates (FS) for seed treatment, solutions (LS) for seed treatment, water-dispersible powders (WS) for seed treatment, capsule suspensions (CF) for seed treatment, gels (GF) for seed treatment, emulsion concentrates (EC), suspension concentrates (SC), suspension emulsions (SE), capsule suspensions (CS), water-dispersible granules (WG), emulsified granules (EG), water-in-oil emulsions (EO), oil-in-water emulsions (EW), microemulsions (ME), oil dispersions (OD), oil-soluble flow concentrates (OF), oil-soluble liquids (OL), soluble concentrates (SL), ultra-low volume suspensions (SU), ultra-low volume liquids (UL), technical concentrates (TK), dispersible concentrates (DC), wettable powders (WP), or any technically feasible formulation, in combination with agriculturally acceptable adjuvants. As with the composition type, the choice of application method (e.g., spraying, atomizing, dusting, dispersing, coating, or watering) depends on the intended purpose and the specific circumstances. The composition may also contain other adjuvants, such as stabilizers, defoamers, viscosity modifiers, binders or thickeners, as well as fertilizers, micronutrient donors, or other formulations to achieve specific effects.

[0221] Such compositions can be prepared using conventional methods, such as mixing the active ingredient with appropriate formulation inert substances (diluents, solvents, fillers, and optional other formulation components, such as surfactants, biocides, antifreeze agents, thickeners, and compounds that provide adjuvant effects). Furthermore, conventional sustained-release formulations can be used if a sustained therapeutic effect is required. Formulations for sprays, such as water-dispersible concentrates (e.g., EC, SC, DC, OD, SE, EW, EO, etc.), wettable powders, and granules, may contain surfactants (e.g., wetting agents and dispersants) and other compounds that provide adjuvant effects, such as condensation products of formaldehyde and naphthalene sulfonates, alkyl aryl sulfonates, lignin sulfonates, fatty alkyl sulfates, and ethoxylated alkylphenols and ethoxylated fatty alcohols.

[0222] The compounds or compositions of formula (I) of this invention are typically mixed with an inert carrier (such as a solid carrier, liquid carrier, or gas carrier), and surfactants or other auxiliaries may be added if necessary to form an emulsion. This invention can be formulated into oils, powders, granules, wettable powders, granular wettable powders, flow aids, dry powder flow aids, microcapsules, aerosols, poison baits, resin formulations, paste formulations, foaming agents, carbon dioxide gas formulations, etc. These formulations can be processed and used as mosquito coils, electric mosquito repellent mats, liquid mosquito repellent formulations, fumigants, fumigants, and tablet formulations. These formulations typically contain 0.01 to 95% by weight of the compound or composition of formula (I) of this invention.

[0223] Suitable agricultural adjuvants and carriers for formulating the above-described formulations of the present invention are well known to those skilled in the art.

[0224] In this article, pesticides are referred to by their common names and are widely known, for example, see "The Pesticide Manual", 15th Ed., British Crop Protection Council 2009.

[0225] Furthermore, the compositions of the present invention can also be used with one or more systemically acquired resistance inducers (“SAR” inducers). SAR inducers have been described, for example, in U.S. Patent 6,919,298, including, for example, salicylates and the commercially available SAR inducer thiadiazole-S-methyl. Compounds of formula (I) are generally used in the form of agrochemical compositions, which can be applied simultaneously or sequentially to the crop or plant to be treated with other compounds. These other compounds can be, for example, fertilizers, micronutrient donors, or other formulations that influence plant growth. They can also be selective or non-selective herbicides, as well as insecticides, fungicides, bactericides, nematicides, molluscicides, or mixtures of several of the above formulations, and, if desired, can be used with carriers, surfactants, or application promoters commonly used in the formulation field.

[0226] Application can be carried out before or during sowing.

[0227] The application methods of compounds of formula (I), combinations thereof, and compositions thereof for use in plant propagation materials, particularly seeds, include dressing, coating, granulation, dusting, and soaking, as well as in-furrow application. Preferably, compounds of formula (I), combinations thereof, and compositions thereof are applied to the plant propagation material by methods that do not induce germination, such as dressing, granulation, coating, and dusting.

[0228] When used for plant protection, the amount of active substance applied is 0.001 to 5 kg per hectare, preferably 0.005 to 3 kg per hectare, more preferably 0.05 to 1.0 kg per hectare, and especially preferably 0.1 to 1.0 kg per hectare, depending on the desired effect.

[0229] When processing plant propagation material (e.g., seeds) (e.g., by dusting, coating or soaking), 0.1 to 5000 grams of active substance are typically required per 100 kg of plant propagation material (preferably seeds), preferably 1 to 1000 grams of active substance, and more preferably 1 to 100 grams of active substance.

[0230] When used to protect materials or store products, the amount of active substance applied depends on the area of ​​application and the desired effect. Typically, the amount used to protect materials is 0.001 g to 5 kg per cubic meter of treated material, preferably 0.005 g to 1 kg of active substance.

[0231] Various types of oils, wetting agents, adjuvants, fertilizers or micronutrients, and other pesticides (e.g., herbicides, insecticides, fungicides, growth regulators, safeners, biopesticides) can be added as premixes to the active substance or a composition containing the active substance, or, where appropriate, can be added immediately before use (tank mixing). These additives can be mixed with the compositions of the present invention at a weight ratio of 1:100 to 100:1.

[0232] The compound of formula (I) can be used in the form of a composition for controlling or preventing harmful pests and / or plant pathogenic microorganisms, the composition comprising at least one compound of formula (I) or at least one preferred single compound as defined herein (in free form or in the form of a salt available for agrochemicals) as an active ingredient, and at least one of the above adjuvants.

[0233] Therefore, the present invention provides a composition comprising at least one compound of formula (I), an agriculturally acceptable carrier, and optional adjuvants. An agriculturally acceptable carrier refers, for example, a carrier suitable for agricultural use. Agricultural carriers are well known in the art. Preferably, the composition may comprise at least one or more insecticidal compounds, for example, in addition to the compound of formula (I), it may also comprise an additional fungicidal active ingredient.

[0234] The compound of formula (I) may be the sole active ingredient in the composition or may be mixed with one or more other active ingredients (e.g., pesticides, fungicides, insecticides, herbicides or plant growth regulators).

[0235] Other suitable active ingredients include the following: cyclic amino acid fungicides, aliphatic nitrogen fungicides, amide fungicides, aniline fungicides, antibiotic fungicides, aromatic fungicides, arsenic fungicides, arylphenyl ketone fungicides, benzamide fungicides, benzoylaniline fungicides, benzimidazole fungicides, benzothiazole fungicides, plant-derived fungicides, bridged diphenyl fungicides, carbamate fungicides, carbanilate fungicides, conazole fungicides, copper fungicides, dicarboxyimide fungicides, dinitrophenol fungicides, dithiocarbamate fungicides, dithiohexacyclopentane fungicides, furanamide fungicides, furans. Aniline fungicides, hydrazide fungicides, imidazole fungicides, mercury fungicides, morpholine fungicides, organophosphate fungicides, organotin fungicides, oxadiene fungicides, oxazole fungicides, benzenesulfonamide fungicides, polysulfide fungicides, pyrazole fungicides, pyridine fungicides, pyrimidine fungicides, pyrrole fungicides, quaternary ammonium fungicides, quinoline fungicides, quinone fungicides, quinoxaline fungicides, methoxyacrylate fungicides, sulfonylaniline fungicides, thiadiazole fungicides, thiazolidine fungicides, thiocarbamate fungicides, thiophene fungicides, triazine fungicides, triazole fungicides, triazolopyrimidine fungicides, urea fungicides, valerate fungicides, and zinc fungicides.

[0236] The active ingredient mixture of the compound of formula (I) and the above-mentioned active ingredient is preferably mixed in a mixing ratio of 1000:1 to 1:5000, more preferably in a mixing ratio of 500:1 to 1:500, and even more preferably in a mixing ratio of 100:1 to 1:100. These mixing ratios are all by weight.

[0237] The above mixture can be used in a pest control method, which includes applying a composition containing the above mixture to a pest or its environment.

[0238] The mixture comprising the compound of formula (I) and one or more active ingredients as described above can be applied in various forms, for example, as a single "premix," as a combined spray mixture (e.g., a "can mix") consisting of individual formulations of single active ingredient components, or as a sequential application of single active ingredients, i.e., one after another over short time intervals (e.g., hours or days). The order of application of the compound of formula (I) and the active ingredient as described above is not necessary for the implementation of this invention.

[0239] When the compound of formula (I) and the insecticidal active substance are applied sequentially, the time interval between the two applications can range from, for example, 2 hours to 7 days. Furthermore, a wider range of intervals can be used, for example, from 0.25 hours to 30 days, preferably from 0.5 hours to 14 days, especially from 1 hour to 7 days or from 1.5 hours to 5 days, and even more preferably from 2 hours to 1 day. In the binary mixtures and compositions according to the invention, the weight ratio of component 1) and component 2) generally depends on the nature of the active ingredient used, typically 1:1000 to 1000:1, commonly 1:100 to 100:1, conventionally 1:50 to 50:1, preferably 1:20 to 20:1, more preferably 1:10 to 10:1, even more preferably 1:4 to 4:1, and particularly preferably 1:2 to 2:1.

[0240] The compositions according to the invention are prepared in known ways, for example, by grinding, sieving, and / or compressing the solid active ingredient without the use of adjuvants; or, in the presence of at least one adjuvant, by thoroughly mixing and / or grinding the active ingredient with the adjuvant (multiple adjuvants). The invention also relates to methods for preparing the compositions and the use of compounds of formula (I) in the preparation of these compositions.

[0241] Therefore, the compounds and compositions of the present invention can be used agronomically to protect field crops from phytophagous invertebrate pests, and agronomically to protect other horticultural crops and plants from phytophagous invertebrate pests. This use includes protecting crops and other plants (i.e., agronomic and non-agronomic plants) that contain genetic material introduced through genetic engineering (i.e., transgenics) or modified through mutagenesis to confer advantageous traits. The compounds of the present invention are characterized by good metabolic and / or soil residue properties and exhibit control activity against a variety of agronomic and non-agronomic invertebrate pests. The compounds of the present invention are active ingredients with preventative and / or therapeutic value in the field of pest control, effectively controlling pesticide-resistant pests, such as insects and fungi, even at low doses, and / or possessing a very desirable biocidal spectrum, with good tolerance to warm-blooded animals, fish, and plants.

[0242] In another embodiment, the compounds and compositions of formula (I) according to the invention are suitable for use as fungicides. They are characterized by their effectiveness against a variety of plant pathogenic fungi, including soil-borne fungi, particularly those belonging to the classes Plasmodiophoromycetes, Peronosporomycetes (Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, and Deuteromycetes (Incomplete Fungi). Some compounds have systemic action and can be used as foliar fungicides, seed dressing fungicides, and soil fungicides in crop protection. Furthermore, they are suitable for controlling harmful fungi, particularly those present in the xylem or roots of plants.

[0243] Compounds of formula (I) and their compositions are preferably used to control plant pathogenic fungi and insects on various cultivated plants, such as cereals (e.g., wheat, rye, barley, triticale, oats, or rice); sugar beets, fruits, legumes (e.g., soybeans), oil crops, cucurbitaceous crops, fiber plants, citrus fruits, vegetables, Lauraceae plants, energy and raw material crops, corn; tobacco; nuts; coffee; tea; bananas; grapevines (table grapes and grape juice grapevines); natural rubber plants; or ornamental and forestry plants; and pathogenic fungi and insects on plant propagation materials (e.g., seeds); and pathogenic fungi and insects on the crop material of these plants.

[0244] According to the present invention, all the above-mentioned cultivated plants are understood to include all species, subspecies, varieties, cultivars and / or hybrids belonging to the corresponding cultivated plants, including but not limited to winter varieties and spring varieties, especially cereals such as wheat and barley, as well as winter varieties and spring varieties of rapeseed, such as winter wheat, spring wheat, winter barley, etc.

[0245] Maize is also known as Indian maize or corn ( Corn This includes all types of maize, such as field maize and sweet maize. According to the invention, all soybean cultivars or varieties are included, particularly indeterminate and determinate cultivars or varieties.

[0246] The term "cultivated plant" should be understood to include plants that have been modified through mutagenesis or genetic engineering to give them new traits or change their existing traits.

[0247] Compounds of formula (I), combinations thereof, or combinations thereof can be used to treat a variety of fungal pathogens. Non-limiting examples of fungal disease pathogens that can be treated according to the present invention include: Ustilaginales, such as rice false smut fungus ( Virens stilaginoidea ), Ustilago nudum ( Naked scald ), Ustilago tritici ( Wheat blight ), corn smut ( I burn the zea. For example, rust caused by stalk rust fungi, such as *Grewia ficus-indica* (fig rust fungi). Cerotelium fig ), bearberry rust fungus ( Chrysomyxa arctostaphyli ), sweet potato sheath rust fungus ( Coleosporium ipomoea ), coffee camel rust fungus ( Hemileia the badass ), peanut stalk rust fungus, ( Puccinia arachidis ), Mexican cotton rust fungus ( Powdery mildew cacao ), stalk rust fungus ( Puccinia graminis ), Hidden stalk rust fungus ( Puccinia confidata ), sorghum stalk rust fungus ( Puccinia sorghum ), barley stalk rust fungus ( Barley powdery mildew ), barley stripe rust ( Powdery mildew striiformis f.sp. Horde ), Rye Stripe Rust ( Puccinia striiformis f.sp. Secalis ), Hazelnut rust fungus ( Pucciniastrum coryli ), or Uredinales, such as Curcuma przewalskii ( Cronartium red currant ), Juniperus chinensis rust fungus ( Gymnosporangium juniper-virginianae Poplar leaf rust fungus ( Melampsora jellyfish ), yam bean rust fungus ( Phakopsora pachyrhizi ), short-pointed multicellular rust fungus ( Phragmidium mucronatum ), Physopella ampelosidi ), Peach brown rust fungus ( Transchelia discolored ), broad bean rust fungus ( Uromyces viciae-fabae ); and other rots and diseases, such as those caused by the following pathogens: Cryptococcus ( Cryptococcus spp. ), tea cake bacteria ( Exobasidium vexans ), Marasmiellus inoderma genus *Schefflera* ( Mycena spp. ), corn silk cob smut ( Sphacelotheca royal ), Ishikari Bay Sclerotinia ( Typhula ishikariensis ), Ice plant smut ( Urocyst wheatgrass ), Itersonilia perplexans Due to *Vorticella esculenta* ( The unsightly bark ), Joyful fusiform Spiral-shaped basidiomycetes ( Waitea circina Rhizoctonia solani ( ) Rhizoctonia solani ), Gua cylindrica ( Cucumber beetle ), Dahlia leaf smut ( Entyloma dahliae ), Entylomella microsporeMolin New Ustilago maydis ( Neovossia milliniae ) and wheat net smut ( Tilletia caries Blastocystis fungi, such as *Blastocladiomycetes* (…). Physoderma maydis Mucor ( ) Mucoromycetes ), such as melon hair mold ( Choanephora cucurbitarum Mucor ( ) Mucor spp. ) and Rhizopus septemlobus ( Rhizopus arrhizus ).

[0248] In another embodiment, the disease is caused by rust pathogens, such as Gymnosporangium species, for example, pear gum rust ( Gymnosporangium sabinae ); Hemileia genus, for example, coffee rust ( Hemileia the destroyer Phakopsora, for example, *Phakopsora* (bean rust fungus). Phakopsora pachyrhizi ) or soybean rust fungus ( Phakopsora meibomiae ); genus *Puccinia*, for example, *Puccinia cryptica* (… Puccinia confidata ), stalk rust fungus ( Puccinia graminis ) or stripe rust ( Puccinia striiformis ); genus *Uromyces*, for example, *Uromyces beanus* (… Uromyces appendicitis ); Specifically, *Pseudomonas syringae* (… Cronartium ribicola (White pine blister rust); Juniperus chinensis rust fungus ( Gymnosporangium juniper-virginianae (Cedar-Apple rust); Coffee camel rust fungus ( Hemileia destroyer (coffee rust); soybean rust fungus ( Phakopsora meibomiae ) and yam bean rust fungus ( P. pachyrhizome (Soybean rust); Crown rust fungus ( Puccinia coronata (Oat and ryegrass crown rust); stalk rust fungus ( Puccinia graminis (Wheat and meadow early-maturing rice stem rust, or cereal black rust); daylily rust fungus ( Puccinia hemerocallidis (Hemerocallis rust); Wheat leaf rust fungus ( Puccinia persistens subsp. Triticina (wheat rust, also known as brown rust or red rust); Corn stalk rust fungus ( Puccinia sorghum (Corn rust); Stripe rust fungus ( Puccinia striiformis (Cereal yellow rust); Bean rust fungus ( Uromyces appendicitis (Bean rust); Bean rust fungus ( Uromyces beanoli (Bean rust); Sugarcane black stalk rust fungus ( Puccinia melanocephala(Sugarcane brown rust); Sugarcane truffle rust fungus ( Puccinia kuehnii (Sugarcane orange rust).

[0249] The plants that can be treated according to the present invention include the following: cotton, flax, grapes, fruits, and vegetables, such as Rosaceae (e.g., pome fruits like apples, pears, apricots, cherries, apricots, and peaches), Curcumaceae, Juglandaceae, Betulaceae, Anacardiaceae, Fagaceae, Moraceae, Oleaceae, Actinidiaceae, Lauraceae, Musaceae (e.g., banana trees and banana plantations), Rubiaceae (e.g., coffee), Theaceae, Sterculiaceae, Rutaceae (e.g., lemons, oranges, and grapefruits); Vitaceae (e.g., grapes); Solanaceae (e.g., tomatoes, peppers), Liliaceae, Asteraceae (e.g., lettuce), Apiaceae, Brassicaceae, Chenopodiaceae, Cucurbitaceae (e.g., cucumbers), Allium family (e.g., leeks, onions). ), Fabaceae (e.g., peas); major crops, such as Gramineae (e.g., corn, turf, wheat, rye, rice, barley, oats, millet, and triticale), Asteraceae (e.g., sunflower), Brassicaceae (e.g., head cabbage, purple cabbage, broccoli, cauliflower, Brussels sprouts, bok choy, kohlrabi, radish, rapeseed, mustard greens, horseradish, and watercress), Fabaceae (e.g., beans, peanuts), Fabaceae (e.g., soybeans), Solanaceae (e.g., potatoes), Chenopodiaceae (e.g., beets, forage beets, Swiss chard, beetroot); Malvaceae (e.g., cotton); useful and ornamental plants in gardens and woodlands; and genetically modified varieties of these plants.

[0250] The key to soybean disease control lies in controlling the following fungal diseases affecting leaves, stems, pods, and seeds, such as those caused by Alternaria leaf spot (Alternaria leaf spot). Altemaria spec. atrans tenuissima ),anthrax( Colletotrichum gloeosporoides dematium var. truncatum Brown spot disease ( Septoria wisteria Cercospora leaf spot and wilt ( Cercospora kikuchii ), leaf blight ( Choanephora trispora infundibulum (Syn . Soybean red leaf spot disease Dactuliophora glycine Downy mildew ( Downy mildew (Peronospora manshurica) Deschoenlein leaf blight ( Drechslera glycine Frog eye disease ( Cercospora soybean Clover leaf spot disease ( Leptosphaerulina trifolii ) and leaf spot disease of the genus *Leymus* ( phyllostica leaf spot () Phyllosticta sojaecola ), pods and stem blight ( Phomopsis soybeans ),powdery mildew( Microsphere diffuse ), Echinococcus leaf spot ( Pyrenochaeta sweetines Rhizoctonia solani, affecting the aboveground parts, leaves, and reticulate blight ( Rhizoctonia solani ), rust ( Phakopsora pachyrhizi, Phakopsora meibomiae ), scabies ( Sphaceloma glycine ), stem and leaf blight ( Stemphylium lumpy ), target spot disease ( Corynespora cassicola Fungal diseases affecting the roots and base of the stem, such as those caused by: black root rot (… Calonectiia crotalariae ), carbonized rot ( Macrophomina Phaseolina Fusarium wilt or Fusarium wilt, root rot, pod and neck rot ( Fusarium oxysporum, Fusarium orthoceras Fusarium semitectum、Fusarium equiseti ), mycobacterial root rot ( Mycoleptodiscus terrestrial ), peanut basal rot ( Neocosmospora vasinfecta Pods and stem blight ( Diaporthe Beans ), stem canker ( Diaporthe Beanolorum var. caulivora Phytophthora rot ( Phytophthora megasperma Brown stem rot ( Phialophora gregata ), Pythium disease ( Pythium aphanidennatum , Pythium irregulare , Pythium debaryanum , Pythium myriotylum , Pythium ultimate) Rhizoctonia solani root rot, stem rot and damping-off ( Rhizoctonia solani ), Sclerotinia stem rot ( Sclerotinia sclerotiorum Large white sclerotium disease ( Sclerotinia rolfsii ), root rot caused by *Lysimachia christinae* ( Thielaviopsis basicola ).

[0251] This invention also relates to the use of compounds of formula (I), combinations thereof, or compositions thereof in the prevention and control of the following plant diseases: various *Stripe rust* species (rusts) on plants, such as, but not limited to, *Stripe rust* (brown rust or leaf rust), *Stripe rust* (stripe rust or yellow rust), *Stripe rust* (dwarf rust), *Stripe rust* (stem rust or black rust), or *Stripe rust* (brown rust or leaf rust) on cereals such as wheat, barley, or rye, and various *Rusceae* fungi on plants, particularly *Stripe rust* on soybeans (… Phakopsora pachyrhizi ) and soybean rust fungus ( P. meibomiae ), coffee camel rust fungus ( Hemileia destroyer ), bean rust fungus ( Uromyces appendiculatus ), broad bean rust fungus ( Uromyces bean ) and bean rust fungus ( Uromyces beanoli ).

[0252] Compounds of formula (I) and their combinations are particularly effective against the following plant pathogens: rust on soybeans and cereals (e.g., *Sclerotium spp.* and *Sclerotium spp.* on soybeans; *Sclerotium spp.* and *Sclerotium spp.* on wheat); molds on specialty crops, soybeans, rapeseed, and sunflowers (e.g., *Botrytis cinerea* on strawberries and grapevines, *Sclerotium spp.*, *Sclerotium spp.*, and *Sclerotium rolfe* on rapeseed, sunflowers, and soybeans); Fusarium diseases on cereals (e.g., *Fusarium spp.* and *Fusarium graminearum* on wheat); downy mildew on specialty crops (e.g., *Phytophthora infestans* on grapevines, *Phytophthora infestans* on potatoes); powdery mildew on specialty crops and cereals (e.g., *Hydnophorus spp.* on grapevines, various *Powdery mildew* species on specialty crops, *Powdery mildew* on cereals); and leaf spot diseases on cereals, soybeans, and maize (e.g., *Gnaphalium glomerulosa* and *Gnaphalium nodosa* on cereals, *Gnaphalium glomerulosa* on soybeans, *Cercospora* species on maize and soybeans).

[0253] One aspect of the present invention relates to a method for protecting plants susceptible to and / or suffering from infection by plant pathogenic fungi containing an F129L amino acid substitution in mitochondrial cytochrome b protein to confer resistance to Qo inhibitors, the method comprising: applying at least one compound of formula (I) or a composition thereof to the plant, treating plant propagation material of the plant with at least one compound of formula (I) or a composition thereof, and / or applying at least one compound of formula (I) or a composition thereof to the plant pathogenic fungi.

[0254] According to another embodiment, a method for controlling plant pathogenic fungi includes: a) identifying plant pathogenic fungi containing an amino acid substitution F129L in the mitochondrial cytochrome b protein that confers resistance to Qo inhibitors, or identifying materials, plants, soil, or seeds susceptible to infection by plant pathogenic fungi as defined herein; and b) treating the fungi or materials, plants, soil, or plant propagation materials with an effective amount of at least one compound of formula (I) or a composition containing the compound.

[0255] The term "plant pathogenic fungus containing F129L amino acid substitutions in mitochondrial cytochrome b protein that confer resistance to Qo inhibitors" should be understood as at least 10% of the fungal isolate to be controlled, preferably at least 30%, more preferably at least 50%, more preferably at least 75%, and most preferably between 90% and 100%; particularly preferably between 95% and 100% of the fungal isolate to be controlled, containing F129L amino acid substitutions in mitochondrial cytochrome b protein, thereby conferring resistance to Qo inhibitors.

[0256] Furthermore, this invention relates to the application of compounds of formula (I) as defined herein for the control of plant pathogenic fungi, which contain an F129L amino acid substitution in the mitochondrial cytochrome b protein to confuse it with resistance to Qo inhibitors.

[0257] As used herein, “Qo inhibitors” include any substance that can reduce and / or inhibit respiration by binding to the ubiquinone oxidative center of the cytochrome bc1 complex in mitochondria. This oxidative center is typically located on the outer side of the inner mitochondrial membrane.

[0258] The F129L mutation in the cytochrome b (cytb, also known as cob) gene refers to any substitution of the nucleotide in the codon encoding "F" (phenylalanine; e.g., TTT or TTC) that results in the codon encoding "L" (leucine; e.g., TTA, TTG, TTG, CTT, CTC, CTA, or CTG). For example, replacing the first nucleotide "T" in codon 129 with "C" (TTT replaced with CTT) results in the 129th amino acid in the cytochrome b gene being replaced by L (leucine) instead of F (phenylalanine) (F129L). In this invention, the F129L mutation in the cytochrome b gene refers to the 129th amino acid in the cytochrome b protein being replaced by L (leucine) instead of F (phenylalanine) (F129L).

[0259] Many other plant pathogenic fungi have also acquired the F129L mutation in the cytochrome b gene, thus conferring resistance to Qo inhibitors, such as rust fungi, particularly soybean rust (Potamogeton bean rust). Phakopsora pachyrhizi )and Phakopsora meibromiae ), as well as fungi of the genera *Alternaria*, *Pyrenophora*, and *Rhizoctonia*. Preferred fungal species include *Alternaria solanacea* (…). Alternaria solani ), yam bean rust fungus ( Phakopsora pachyrhizi ), Phakopsora meibromiae Barley net spot disease ( Pyrenophora smooth ), Sclerotium truncatum ( Pyrenophora tritici-repentis ), wheat leaf blight pathogen (Zymoseptoriatritici), Corynebacterium spp., Cercospora spp. Cercospora spp. ) and Rhizoctonia solani ( Rhizoctonia solani In particular, the rust fungus of the potato layer ( Phakopsora pachyrhizi ).

[0260] One aspect of the present invention relates to a method for protecting plants susceptible to and / or currently infected by plant pathogenic fungi, wherein the mitochondrial cytochrome b protein of the plant pathogenic fungi contains a G143A amino acid substitution, thereby conferring resistance to Qo inhibitors. The method comprises: applying at least one compound of formula (I) or a composition comprising the compound to the plant; treating propagation material of the plant with at least one compound of formula (I) or a composition comprising the compound; and / or applying at least one compound of formula (I) or a composition comprising the compound to the plant pathogenic fungi.

[0261] The compounds of formula (I) and their compositions are also suitable for controlling harmful pests and / or microorganisms, protecting stored products or harvests, and protecting materials.

[0262] Compounds of formula (I) can be used alone or in combination to protect fungi, plants and plant propagation materials (e.g., seeds), soil, surfaces, materials, or rooms from fungal infection by treating them with an effective fungicidal amount of the active substance. This application can be performed before and after fungal infection of the plants, plant propagation materials (e.g., seeds), soil, surfaces, materials, or rooms.

[0263] These seedlings can also be fully or partially protected by soaking or watering before transplanting.

[0264] Preferably, plant propagation material is treated with compounds of formula (I), combinations thereof, or compositions thereof to control a variety of fungi on cereals (such as wheat, rye, barley, and oats), rice, corn, cotton, and soybeans.

[0265] Furthermore, this invention also covers plants that utilize recombinant DNA technology to synthesize one or more proteins to enhance their resistance or tolerance to bacterial, viral, or fungal pathogens. Examples of such proteins include so-called "pathogenesis-associated proteins" (PR proteins, e.g., see EP392225), plant resistance genes (e.g., potato varieties expressing resistance genes against Phytophthora infestans, a pathogenic fungus derived from the Mexican wild potato *Solanum bulbocastanum*), or T4 lysozyme (e.g., potato varieties capable of synthesizing such proteins to enhance their resistance to bacteria such as *Pythium blight*). Methods for producing such genetically modified plants are generally known to those skilled in the art, for example, as described in the aforementioned publications.

[0266] Furthermore, the ability to use recombinant DNA technology to enable plants to synthesize one or more proteins to improve productivity (e.g., biomass yield, grain yield, starch content, oil content, or protein content), enhance plant tolerance to drought, salinity, or other limiting environmental factors, or improve tolerance to pests and pathogens such as fungi, bacteria, or viruses is also within the scope of this invention.

[0267] Furthermore, this invention also covers plants containing altered or novel components through recombinant DNA technology to improve human or animal nutrition, such as oil crops that produce healthy long-chain omega-3 fatty acids or unsaturated omega-9 fatty acids (e.g., Dow AgroSciences' Nexera® canola).

[0268] Furthermore, the present invention also covers plants containing altered or novel components through recombinant DNA technology to improve the production of raw materials, such as potatoes that produce more amylopectin (e.g., Amflora® potatoes from BASF, Germany).

[0269] This invention also relates to a method for preventing plant pathogenic microorganisms from infecting crops and / or horticultural crops, wherein an effective amount of at least one compound of formula (I) of this invention, a composition thereof, or a composition thereof is applied to plant seeds. The compounds, combinations, and compositions of this invention can be used to prevent and control plant diseases.

[0270] Compounds of formula (I), combinations thereof, and compositions thereof are also applicable to the control of harmful fungi, thereby protecting stored products or harvests and materials. The term "material protection" refers to the protection of technical and non-biological materials (e.g., adhesives, glues, wood, paper and paperboard, textiles, leather, coating dispersions, plastics, cooling lubricants, fibers, or fabrics) from the contamination and damage of harmful microorganisms (e.g., fungi) and pests (e.g., insects).

[0271] In the protection of wood and other materials, special attention should be paid to the following harmful fungi: ascomycetes, such as those of the genus *Leptochloa* (…). Ophiostoma spp. ), genus *Ceratophyllum* ( Ceratocystis spp. ), Aureobasidium pullulans ( Aureobasidium sprouting ), genus Sclerosporum ( Sclerophoma spp. ), genus Chaetomium ( Chaetomium spp. ), saprophytic fungi ( Humicola spp. Petrilla spp. Petriella spp. Mucor ( ) Trichurus spp. Basidiomycetes, such as the genus *Pteris* (…). Coniophora spp. ), Coriolus spp. genus *Pleurotus* ( Gloeophyllum spp. ), Lentinus genus ( Lentinus spp. ), Pleurotus ( Pleurotus spp.), genus *Phospora* Poria spp. ), genus *Dry Rot Fungi* Serpula spp. ) and the genus *Cryptotympany* Tyromyces spp. Deuteromycetes, such as Aspergillus ( Aspergillus spp. Cladosporium ( Cladosporium spp. ), Penicillium ( Penicillium spp. Trichoderma ( ) Trichoderma spp. Alternaria ( ) Altemaria spp. ), Penicillium genus ( Paecilomyces spp. ); and zygomycetes, such as Mucor ( Mucor spp In addition, the following yeasts are of interest in protecting stored products and harvested goods: Candida and Saccharomyces cerevisiae.

[0272] In one embodiment, compounds of formula (I), combinations thereof, and compositions thereof are particularly suitable for controlling the following plant disease: soybean rust on soybeans ( Phakopsora pachyrhizi and P. meibomiae ), as well as leaf spot diseases caused by the genera *Cercospora* and *Corynespora*.

[0273] The present invention also relates to a method for controlling plant pathogenic fungi. The method comprises treating fungi, or materials, plants, plant parts, their locations, soil or seeds to be protected from fungal invasion, with an effective amount of at least one compound of formula (I), a combination or composition comprising at least one compound of formula (I).

[0274] Compounds of formula (I), combinations thereof, and compositions thereof can be used to improve plant health. The present invention also relates to a method for improving plant health by treating plants, their propagation material, and / or the locations where plants are growing or intended to grow, respectively, with effective amounts of compounds of formula (I) and compositions thereof.

[0275] The term "plant health" should be understood as the state of a plant and / or its products, determined individually or in combination by several indicators, such as yield (e.g., increased biomass and / or increased content of valuable components), plant vigor (e.g., improved plant growth and / or greener leaves ("greening effect")), quality (e.g., improved content or composition of certain components), and tolerance to abiotic and / or biotic stresses. These plant health indicators may be interdependent or mutually causal.

[0276] Another aspect of the invention relates to the use of a compound of formula (I) as a fungicide, either alone or in combination, to treat fungi or plants, plant propagation material (e.g., seeds), soil, surfaces, materials, or rooms to protect them from fungal invasion. This application can be performed before and after the plants, plant propagation material (e.g., seeds), soil, surfaces, materials, or rooms have been infected by fungi.

[0277] Plant propagation material may be treated with a compound of formula (I), or a combination thereof, to achieve a protective effect. This treatment may be carried out before or during planting or transplanting.

[0278] Chemical Examples: The following examples illustrate the preparation methods and processes of the compounds of the present invention, but are not intended to limit them, and include the inventors' preferred mode for carrying out the present invention.

[0279] Example 1 Preparation of (Z)-3-methoxy-2-(2-methyl-5-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenoxy)methyl acrylate

[0280] Step 1: Preparation of methyl 2-(5-bromo-2-methylphenoxy)acetate

[0281] Potassium carbonate (14.78 g, 107 mmol) was added to a stirred solution of 5-bromo-2-methylphenol (10 g, 53.5 mmol) and methyl 2-bromoacetate (7.59 mL, 80 mmol) in tetrahydrofuran (100 mL). The reaction mixture was stirred at 65°C for 12 hours. After the reaction was complete, the reaction mixture was cooled to 25°C, diluted with water (100 mL), and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure to give an oily residue, which was purified by rapid column chromatography to give methyl 2-(5-bromo-2-methylphenoxy)acetate (11.77 g, 45.4 mmol, 85% yield) as a brown viscous liquid.

[0282] 1 H-NMR (400 MHz, DMSO- d 6) δ 7.11 (dd, J = 7.8, 0.5 Hz, 1H), 7.07-7.04(m, 2H), 4.88 (d, J = 9.3 Hz, 2H), 3.69 (d, J= 4.9 Hz, 3H), 2.15 (d, J = 14.7 Hz, 3H); MS: m / z = 259.26. [M+1]. Step 2: Preparation of methyl 2-(5-bromo-2-methylphenoxy)-3-hydroxyacrylate

[0283] Under nitrogen protection, sodium methoxide (3.34 g, 61.8 mmol) was added in portions to a stirred solution of methyl 2-(5-bromo-2-methylphenoxy)acetate (8 g, 30.9 mmol) and methyl formate (11.53 mL, 185 mmol) in tetrahydrofuran (30 mL). The reaction mixture was stirred at 25°C for 1 hour. After the reaction was complete, the reaction mixture was poured into ice water (100 mL), neutralized with 1N hydrochloric acid (pH approximately 5-6), and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure to give methyl 2-(5-bromo-2-methylphenoxy)-3-hydroxyacrylate (6.21 g, 21.61 mmol, 70% yield), a viscous gel that required no further purification and was used directly in the next reaction.

[0284] 1 H-NMR (400 MHz, CDCl3) δ 7.05–7.00 (m, 2H), 6.82 (d, J = 1.5 Hz, 1H), 4.63 (d, J = 5.4 Hz, 2H), 3.81 (s, 3H), 2.25 (d, J = 16.6 Hz, 3H); MS: m / z =288.3. [M+1]. Step 3: Preparation of (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate methyl ester

[0285] Under nitrogen protection, at 25°C, methyl 2-(5-bromo-2-methylphenoxy)-3-hydroxyacrylate (10 g, 34.8 mmol) was subjected to... N,NPotassium carbonate (7.22 g, 52.2 mmol) and methyl iodide (2.2 mL, 34.8 mmol) were added sequentially to a stirred solution of dimethylformamide (30 mL). The reaction mixture was stirred at 25°C for 6 hours. After the reaction was complete, the reaction mixture was diluted with water (100 mL) and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain an oily residue, which was purified by rapid column chromatography to give (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate (6.29 g, 20.90 mmol, yield 60%) as an off-white solid.

[0286] 1 H-NMR (400 MHz, DMSO-d6) δ 7.57 (s, 1H), 7.14 (dd, J = 7.9, 0.6 Hz, 1H), 7.08 (dd, J = 8.1, 2.0 Hz, 1H), 6.78 (d, J = 1.8 Hz, 1H), 3.86 (s, 3H), 3.65 (d, J = 7.0 Hz, 3H), 2.07 (t, J = 2.9 Hz, 3H). MS: m / z = 302.58. [M+1]. Step 4: Preparation of (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxyacrylate methyl ester

[0287] Under nitrogen protection, [XantPhosPd(allyl)]Cl (0.12 g, 0.16 mmol), potassium acetate (0.16 g, 1.66 mmol), and potassium hexacyanoferrate(II) trihydrate (0.77 g, 1.82 mmol) were added to a stirred solution of (Z)-2-(5-bromo-2-methylphenoxy)-3-methoxyacrylate (1 g, 3.32 mmol) in dioxane (10 mL) and water (3.3 mL). The reaction mixture was purged with nitrogen for 10 min to remove oxygen, and stirring was continued at 100°C for 12 h. After the reaction was complete, the reaction mixture was cooled to 25°C, diluted with water (50 mL), and extracted with ethyl acetate (2 × 50 mL). The organic layers were combined, dried with anhydrous sodium sulfate, concentrated under reduced pressure to obtain a solid, and purified by rapid column chromatography to obtain (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxymethyl acrylate (0.49 g, 1.99 mmol, yield 60%), which was an off-white solid.

[0288] 1 H-NMR (400 MHz, DMSO- d 6) δ 7.58 (s, 1H), 7.41-7.36 (m, 2H), 7.11 (d, J = 1.5 Hz, 1H), 3.87 (d, J = 4.9 Hz, 3H), 3.65 (s, 3H), 2.29 (s, 3H); GCMS: m / z= 247.1 [M . ]. Step 5: Preparation of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate methyl ester

[0289] At 0°C, over 5 minutes, 50% aqueous hydroxylamine (0.78 mL, 6.07 mmol) was added dropwise to a stirred solution of (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxyacrylate (1 g, 4.04 mmol) in 15 mL of ethanol. The reaction mixture was then stirred at 25°C for 12 hours. After the reaction was complete, the solid was filtered and dried to give a white solid, the target product.

[0290] 1 H-NMR (400 MHz, DMSO- d 6) δ 9.56 (s, 1H), 7.55 (s, 1H), 7.20-7.14 (m,2H), 7.01 (d, J = 1.5 Hz, 1H), 5.72 (s, 2H), 3.85 (d, J = 11.5 Hz, 3H), 3.64 (d, J = 9.3 Hz, 3H), 2.21 (d, J = 8.1 Hz, 3H); MS: m / z = 280.95. [M+1]. Step 6: Preparation of (Z)-3-methoxy-2-(2-methyl-5-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenoxy)methyl acrylate

[0291] At 0°C, trifluoroacetic anhydride (1.31 mL, 9.28 mmol) was added dropwise to a stirred solution of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate (1.3 g, 4.64 mmol) in tetrahydrofuran (30 mL). The reaction mixture was stirred at 25°C for 12 hours. After the reaction was complete, the reaction mixture was diluted with water (50 mL) and extracted with ethyl acetate (2 × 50 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure to give an oily residue, which was purified by rapid column chromatography to give (Z)-3-methoxy-2-(2-methyl-5-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenoxy)acrylate (1.25 g, 3.50 mmol, 75% yield) as a white solid.

[0292] 1 H-NMR (400 MHz, DMSO- d 6) δ 7.68 (s, 1H), 7.62 (dd, J = 7.7, 1.6 Hz, 1H), 7.44 (d, J = 7.6 Hz, 1H), 7.26 (d, J = 1.7 Hz, 1H), 3.87 (s, 3H), 3.67 (d, J =15.6 Hz, 3H), 2.32 (s, 3H); GCMS: m / z = 358.1 [M . ] Example 2: Alternative method for preparing (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxyacrylate

[0293] Step 1: Preparation of methyl 2-(5-cyano-2-methylphenoxy)acetate Potassium carbonate (19.72 g, 143 mmol) was added to a stirred solution of 3-hydroxy-4-methylbenzonitrile (9.5 g, 71.3 mmol) and methyl 2-bromoacetate (13.6 mL, 143 mmol) in tetrahydrofuran (100 mL) at 25°C. The reaction mixture was stirred at 65°C for 12 hours. After the reaction was complete, the reaction mixture was cooled to 25°C, diluted with ethyl acetate (200 mL), and purified by celite. ®The ethyl acetate layer was filtered through a filter pad. The ethyl acetate layer was washed with water (100 mL) and saturated brine (80 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to give methyl 2-(5-cyano-2-methylphenoxy)acetate (13.2 g, 64.2 mmol, 90% yield), as a brown liquid.

[0294] 1 H-NMR (400 MHz, DMSO-D6) δ 7.38 (s, 1H), 7.36-7.33 (m, 2H), 4.93 (s,2H), 3.73-3.68 (m, 3H), 2.25 (s, 3H); GCMS: m / z = 205.1 [M]. Step 2: Preparation of methyl 2-(5-cyano-2-methylphenoxy)-3-hydroxyacrylate Under argon protection, sodium methoxide (4.74 g, 88 mmol) was added in portions to a stirred solution of methyl 2-(5-bromo-2-methylphenoxy)acetate (9 g, 43.9 mmol) and methyl formate (16.38 mL, 263 mmol) in tetrahydrofuran solution (100 mL) at 25 °C. The reaction mixture was stirred at 25 °C for 2 hours, then poured into an ice-water solution and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were washed with saturated brine (80 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to give crude methyl 2-(5-cyano-2-methylphenoxy)-3-hydroxyacrylate (7.16 g, 30.7 mmol, 70% yield), which was directly used for the next reaction without further purification. GCMS: m / z = 233.1 [M].

[0295] Step 3: Preparation of (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxyacrylate methyl ester Methyl 2-(5-cyano-2-methylphenoxy)-3-hydroxyacrylate (8 g, 34.3 mmol) was subjected to... N,N Potassium carbonate (7.11 g, 51.5 mmol) was added to an ice-cold solution of dimethylformamide (100 mL), and the reaction mixture was stirred for 5 minutes. Iodomethane (3.22 mL, 51.5 mmol) was added dropwise to the reaction system, and the resulting mixture was stirred at 25°C for 16 hours. After the reaction was complete, the reaction mixture was diluted with ethyl acetate (100 mL) and purified by celite. ®The solution was filtered through a filter pad. The filtrate was diluted with water (100 mL) and extracted. The organic layer was separated, and the aqueous layer was extracted again with ethyl acetate (100 mL). The organic layers were combined, washed successively with water (80 mL) and saturated brine (80 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain the crude product. The crude product was purified by rapid column chromatography to give (Z)-2-(5-cyano-2-methylphenoxy)-3-methoxyacrylate (3.82 g, 15.44 mmol, yield 45%) as a solid.

[0296] 1 H-NMR (400 MHz, DMSO- d 6) δ 7.58 (s, 1H), 7.41-7.36 (m, 2H), 7.11 (d, J = 1.5 Hz, 1H), 3.87 (d, J = 4.9 Hz, 3H), 3.65 (s, 3H), 2.29 (s, 3H); GCMS: m / z= 247.1 [M . ]. Example 3: Preparation of (Z)-2-(5-(5-(4-bromophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate

[0297] At 0°C, triethylamine (0.45 mL, 3.21 mmol), 4-bromobenzoic acid (0.22 g, 1.07 mmol), and 1-propanephosphonic anhydride (1.593 mL, 2.68 mmol) were added sequentially to a stirred solution of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate. The reaction mixture was stirred at 90°C for 12 h. After the reaction was complete, the reaction mixture was cooled to 25°C, quenched with saturated sodium bicarbonate solution (10 mL), and extracted with ethyl acetate (2 × 20 mL). The organic layers were combined, dried with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a solid. The solid was purified by rapid column chromatography to give (Z)-2-(5-(5-(4-bromophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate (216 mg, 0.48 mmol, yield 45%), a white solid.

[0298] 1 H-NMR (400 MHz, DMSO- d 6) δ 8.09 (dd, J= 6.6, 2.0 Hz, 2H), 7.87 (dd, J =6.6, 2.0 Hz, 2H), 7.67 (s, 1H), 7.65 (dd, J = 7.6, 1.7 Hz, 1H), 7.42 (d, J = 7.8Hz, 1H), 7.31 (d, J = 1.5 Hz, 1H), 3.89 (s, 3H), 3.66 (s, 3H), 2.32 (s, 3H); MS: m / z = 446.45 [M+1]. Example 4: Preparation of (Z)-2-(5-(5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate

[0299] At 0°C, pyridine (0.173 mL, 2.14 mmol) was added to a stirred solution of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate (500 mg, 1.78 mmol) in toluene (10 mL), followed by dropwise addition of 2-chlorobenzoyl chloride (0.27 mL, 2.14 mmol). The resulting reaction mixture was stirred at 100°C for 16 hours. After the reaction was complete, the reaction mixture was cooled to 25°C, quenched with saturated sodium bicarbonate solution (20 mL), and extracted with ethyl acetate (2 × 20 mL). The organic layers were combined, dried with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain an oily residue. The residue was purified by rapid column chromatography to give (Z)-2-(5-(5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate (450 mg, 1.1 mmol, yield 62.9%) as a white solid.

[0300] 1 H-NMR (400 MHz, DMSO- d 6) δ 8.13 (dd, J = 7.7, 1.3 Hz, 1H), 7.77-7.70 (m,2H), 7.67-7.64 (m, 2H), 7.63-7.59 (m, 1H), 7.43 (d, J = 8.1 Hz, 1H), 7.33 (d, J=1.7 Hz, 1H), 3.88 (s, 3H), 3.66 (s, 3H), 2.32 (s, 3H); MS: m / z = 401.00 [M+1]. Example 5: Preparation of (Z)-3-(3-((1,3-dimethoxy-3-oxoprop-1-en-2-yl)oxy)-4-methylphenyl)-1,2,4-oxadiazole-5-carboxylic acid ethyl ester

[0301] To a stirred solution of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate (900 mg, 3.21 mmol) in toluene (10 mL), pyridine (2.60 mL, 32.1 mmol) was added, followed by dropwise addition of ethyl 2-chloro-2-oxoacrylate (0.43 mL, 4.17 mmol) at 0°C. The resulting mixture was stirred at 90°C for 16 hours. After the reaction was complete, the reaction mixture was cooled to 25°C, quenched with saturated sodium bicarbonate solution (20 mL), and extracted with ethyl acetate (2 × 20 mL). The organic layers were combined, dried with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain an oily residue. The residue was purified by rapid column chromatography to give (Z)-3-(3-((1,3-dimethoxy-3-oxoprop-1-en-2-yl)oxy)-4-methylphenyl)-1,2,4-oxadiazole-5-carboxylic acid ethyl ester (600 mg, 1.656 mmol, yield 51.6%) as an off-white solid.

[0302] 1 H-NMR (400 MHz, CDCl3) δ 7.72 (dd, J = 7.8, 1.7 Hz, 1H), 7.45 (d, J = 1.5Hz, 1H), 7.37 (s, 1H), 7.29 (d, J = 7.3 Hz, 1H), 4.56 (qt, J = 7.1 Hz, 2H), 3.89(s, 3H), 3.71 (s, 3H), 2.41 (s, 3H), 1.49 (t, J = 7.2 Hz, 3H); GCMS: m / z =362.3 [M . ] Example 6: Preparation of (Z)-2-(5-(5-(4-bromophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxy-N-methylacrylamide

[0303] To a stirred solution of methyl(2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate (0.3 g, 0.67 mmol) in tetrahydrofuran (6 mL), a 40% aqueous solution of methylamine (0.07 mL, 0.81 mmol) was added dropwise. The reaction mixture was stirred at 25°C for 12 hours. After the reaction was complete, the reaction mixture was diluted with water (10 mL) and extracted with ethyl acetate (2 × 20 mL). The combined organic layers were washed with saturated brine (10 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain an oily residue. The residue was purified by rapid column chromatography to give (Z)-2-(5-(5-(4-bromophenyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxy-N-methylacrylamide (160 mg, 0.36 mmol, yield 53.5%) as a white solid.

[0304] 1 H-NMR (400 MHz, DMSO- d 6) δ 8.09–8.07 (m, 2H), 7.87 (d, J = 8.6 Hz, 2H), 7.60 (dd, J = 7.7, 1.6 Hz, 1H), 7.43 (d, J = 13.4 Hz, 1H), 7.38 (d, J = 8.1 Hz,1H), 7.31 (s, 1H), 6.60 (d, J = 18.3 Hz, 1H), 3.53 (s, 3H), 2.84 (d, J = 4.6 Hz, 3H), 2.34 (s, 3H). LCMS (M+1) : 445.85. Example 7: (Z)-2-(5-(5-benzyl-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxymethyl acrylate

[0305] Using (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 2-phenylacetyl chloride as starting materials, the synthesis method of (Z)-2-(5-(5-benzyl-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate is the same as that described in Example 3.

[0306] 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.63 (dd, J = 7.6, 1.5 Hz, 1H), 7.40 (d, J = 1.5 Hz, 1H), 7.37–7.32 (m, 5H), 7.31–7.28 (m, 1H), 7.24 (s, 1H), 4.27 (s, 2H), 3.86 (d, J = 7.6 Hz, 3H), 3.69 (d, J = 4.6 Hz, 3H), 2.40 (s, 3H); LCMS(M+1) : 380.9. Example 8: (Z)-3-methoxy-2-(2-methyl-5-(5-(2-phenylprop-2-yl)-1,2,4-oxadiazol-3-yl)phenoxy)methyl acrylate

[0307] The synthesis method for (Z)-3-methoxy-2-(2-methyl-5-(5-(2-phenylpropanoyl)-1,2,4-oxadiazol-3-yl)phenoxy)acrylate using (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 2-methyl-2-phenylpropionyl chloride as starting materials is the same as that described in Example 3.

[0308] 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.63 (dd, J = 7.6, 1.5 Hz, 1H), 7.40 (d, J = 1.5 Hz, 1H), 7.37–7.32 (m, 5H), 7.31–7.28 (m, 1H), 7.24 (s, 1H), 4.27 (s, 2H), 3.86 (d, J = 7.6 Hz, 3H), 3.69 (d, J = 4.6 Hz, 3H), 2.40 (s, 3H); LCMS (M+1): 408.9 Example 9: (Z)-2-(5-(5-(4-fluorophenylethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxymethyl acrylate

[0309] Methyl methoxyacrylate (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 3-(4-fluorophenyl)propionic acid were used as starting materials. The synthesis method of methyl methoxyacrylate (2Z)-2-(5-(5-(4-fluorophenylethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate was the same as that described in Example 2. 1 H-NMR (400 MHz, DMSO- d 6) δ 7.65 (s, 1H), 7.54 (dd, J = 7.7, 1.3 Hz, 1H), 7.36 (d, J = 8.1 Hz, 1H), 7.32 (dd, J = 8.4, 5.7 Hz, 2H), 7.21 (d, J = 1.5 Hz, 1H), 7.10 (t, J = 8.9Hz, 2H), 3.87 (s, 3H), 3.65 (s, 3H), 3.28 (d, J = 7.8 Hz, 2H), 3.09 (t, J =7.6 Hz, 2H), 2.29 (s, 3H); LCMS (M+1): 413.05. Example 10: Preparation of (Z)-3-methoxy-2-(5-(5-(4-methoxy-3-(prop-1-en-2-yl)phenethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)methyl acrylate

[0310] Step 1: Preparation of methyl 3-(4-methoxyphenyl)propionate

[0311] 3-(4-methoxyphenyl)propionic acid (4 g, 22.20 mmol) was added to... N,N In a stirred solution of dimethylformamide (40 mL), potassium carbonate (9.20 g, 66.6 mmol) and methyl iodide (1.7 mL, 26.6 mmol) were added, respectively. The resulting reaction mixture was stirred at 40°C for 4 hours. After the reaction was complete, the reaction mixture was diluted with ethyl acetate (100 mL) and purified by celite. ® The mixture was filtered through a filter pad, and the organic layer was washed with water (30 mL) and saturated brine (20 mL). The organic layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain an oily residue, which was purified by rapid column chromatography to give methyl 3-(4-methoxyphenyl)propionate (4 g, 20.59 mmol, yield 93%) as a pale yellow solid. GC-MS (M + : 194.1).

[0312] Step 2: Preparation of methyl 3-(3-bromo-4-methoxyphenyl)propionate.

[0313]

[0314] At 0°C, aluminum chloride (2.75 g, 20.60 mmol) was slowly added to a stirred solution of methyl 3-(4-methoxyphenyl)propionate (4 g, 20.60 mmol) in dichloromethane (50 mL). The reaction mixture was stirred for 10 minutes, followed by the addition of bromine (1.06 mL, 20.60 mmol) in portions. The reaction mixture was stirred at 25°C for 1 hour. After the reaction was complete, the reaction mixture was slowly poured into a saturated aqueous solution of ammonium chloride (100 mL), and then extracted with ethyl acetate (2 × 80 mL). The combined organic layers were washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, and evaporated under reduced pressure to give an oily residue, which was purified by rapid column chromatography to give methyl 3-(3-bromo-4-methoxyphenyl)propionate (5.2 g, 19.04 mmol, 92% yield). 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.38 (d, J = 2.2 Hz, 1H), 7.10 (dd, J = 8.3, 2.2 Hz, 1H), 6.82 (t, J = 4.2 Hz, 1H), 3.89–3.85 (m, 3H), 3.68 (t, J = 6.2 Hz, 3H), 2.87 (t, J = 7.7 Hz, 2H), 2.61–2.57 (m, 2H). Step 3: Preparation of methyl 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionate

[0315] To a stirred solution of methyl 3-(3-bromo-4-methoxyphenyl)propionate (1.8 g, 6.59 mmol) in 1,4-dioxane (20 mL) and water (5 mL), tripotassium phosphate (2.80 g, 13.2 mmol) and pinacol isopropenylboronic acid (1.85 mL, 9.89 mmol) were added. The mixture was degassed with nitrogen for 10 min, and then PdCl₂(dppf) (1.1 g, 1.32 mmol) was added. The resulting reaction mixture was stirred at 100°C for 3 h. After the reaction was complete, the reaction mixture was diluted with ethyl acetate (50 mL) and water (30 mL), and then precipitated with celite. ®The mixture was filtered through a filter pad. The organic layer was separated, and the aqueous layer was extracted with ethyl acetate (2 × 30 mL). The organic layers were combined, washed with brine (20 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to obtain an oily residue. The residue was purified by rapid column chromatography to give methyl 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionate (1.1 g, 4.69 mmol, yield 71.2%) as an off-white solid. 1 H-NMR (400 MHz, chloroform-D) δ 7.06 (dd, J = 8.3, 2.2 Hz, 1H), 7.02-7.00(m, 1H), 6.83-6.89 (0H), 6.80 (d, J = 8.3 Hz, 1H), 5.14 (td, J = 2.6, 1.2 Hz,1H), 5.04 (q, J = 1.0 Hz, 1H), 3.85-3.78 (m, 3H), 3.67 (s, 3H), 2.89 (t, J =7.8 Hz, 2H), 2.63-2.58 (m, 2H), 2.17-2.05 (m, 3H). GCMS (M+ : 234.1). Step 4: Preparation of 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionic acid

[0316] To a stirred solution of methyl 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionate (900 mg, 3.84 mmol) in tetrahydrofuran (10 mL), methanol (2.00 mL), and water (5.00 mL), lithium hydroxide monohydrate (322 mg, 7.68 mmol) was added, and the resulting mixture was stirred at 25°C for 2 hours. After the reaction was complete, the reaction mixture was acidified with 1N HCl (pH approximately 5), and the aqueous layer was extracted with ethyl acetate (2 x 20 mL). The organic layers were combined, dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to give 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionic acid (0.8 g, 3.63 mmol, 95% yield). 1H-NMR (400 MHz, chloroform-D) δ 7.08 (dd, J = 8.3, 2.4 Hz, 1H), 7.03 (d, J = 2.2Hz, 1H), 6.81 (d, J = 8.3 Hz, 1H), 5.14 (td, J = 2.6, 1.2 Hz, 1H), 5.04 (q, J= 1.0 Hz, 1H), 3.80 (d, J = 9.5 Hz, 3H), 2.90 (t, J = 7.8 Hz, 2H), 2.68-2.64(m, 2H), 2.11 (q, J = 0.7 Hz, 3H); LCMS (M+1): 220.95. Step 5: Preparation of (Z)-3-methoxy-2-(5-(5-(4-methoxy-3-(prop-1-en-2-yl)phenethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)methyl acrylate Methyl (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 3-(4-methoxy-3-(prop-1-en-2-yl)phenyl)propionic acid were used as starting materials. The synthesis method of (Z)-3-methoxy-2-(5-(5-(4-methoxy-3-(prop-1-en-2-yl)phenethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)acrylate was the same as that described in Example 2. 1 H-NMR (400 MHz, chloroform-D) δ 7.64 (dd, J = 7.6, 1.5 Hz,1H), 7.41 (d, J = 1.5 Hz, 1H), 7.36 (s, 1H), 7.28 (s, 1H), 7.10 (dd, J = 8.3,2.4 Hz, 1H), 7.06 (d, J = 2.4 Hz, 1H), 6.81 (d, J = 8.3 Hz, 1H), 5.13 (dt, J= 3.7, 1.6 Hz, 1H), 5.03 (q, J = 1.0 Hz, 1H), 3.88 (s, 3H), 3.81 (s, 3H),3.71 (d, J = 3.7 Hz, 3H), 3.23-3.18 (m, 2H), 3.14-3.09 (m, 2H), 2.41 (s, 3H),2.09 (q, J = 0.7 Hz, 3H); LCMS (M+1): 465.2 Example 11: Preparation of (Z)-2-(5-(5-(1-(4-bromophenoxy)cyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate.

[0317]

[0318] Step 1: Preparation of ethyl 4-bromo-2-(4-bromophenoxy)butyrate

[0319] 4-Bromophenol (0.8 g, 4.56 mmol) was subjected to... N,N Ethyl 2,4-dibromobutyrate (1.13 mL, 5.48 mmol) was added to a stirred solution of dimethylformamide (10 mL), followed by potassium carbonate (1.26 g, 9.13 mmol). The resulting reaction mixture was stirred at 25°C for 12 hours. After the reaction was complete, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate (2 × 20 mL). The combined organic layers were dried over anhydrous sodium sulfate and evaporated under reduced pressure to obtain an oily residue, which was purified by rapid column chromatography to give ethyl 4-bromo-2-(4-bromophenoxy)butyrate (1 g, 2.73 mmol, yield 59.9%) as a colorless liquid. 1 H-NMR(400 MHz, chloroform-D) δ 7.39-7.36 (m, 2H), 6.82-6.78 (m, 2H), 4.80 (dd, J = 8.9,4.0 Hz, 1H), 4.22 (q, J = 7.1 Hz, 2H), 3.63-3.57 (m, 2H), 2.52-2.39 (m, 2H),1.26 (td, J = 7.1, 3.4 Hz, 3H). Step 2: Preparation of ethyl 1-(4-bromophenoxy)cyclopropane-1-carboxylate

[0320] Under nitrogen protection, lithium bis(trimethylsilyl)amino (6.01 mL, 6.01 mmol) was added dropwise to a stirred solution of ethyl 4-bromo-2-(4-bromophenoxy)butyrate (1 g, 2.73 mmol) in 10 mL of tetrahydrofuran solution at -78°C, and the resulting reaction mixture was stirred at -78°C for 2 hours. After the reaction was complete, the reaction mixture was poured into an ice-cold saturated ammonium chloride solution. The aqueous layer was extracted with ethyl acetate (2 × 20 mL), dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to obtain an oily residue, which was purified by rapid column chromatography to give ethyl 1-(4-bromophenoxy)cyclopropane-1-carboxylic acid (650 mg, 2.28 mmol, yield 83%) as a colorless liquid. 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.38–7.32 (m, 2H), 6.82–6.78 (m, 2H), 4.19 (q, J = 7.2 Hz, 2H), 1.60 (dd, J = 8.3, 5.1 Hz, 2H), 1.35–1.28 (m, 2H), 1.19 (t, J = 7.2 Hz, 3H); LCMS (M⁻¹): 285. Step 3: Preparation of 1-(4-bromophenoxy)cyclopropane-1-carboxylic acid

[0321] Lithium hydroxide (302 mg, 12.63 mmol) and 2 mL of water were added to a stirred solution of ethyl 1-(4-bromophenoxy)cyclopropane-1-carboxylic acid (900 mg, 3.16 mmol) in 1,4-dioxane (10 mL). The resulting reaction mixture was stirred at 25°C for 6 hours. The reaction mixture was evaporated and diluted with water (5 mL), washed with ethyl acetate (20 mL), the aqueous layer was acidified with 10% HCl, and then extracted with ethyl acetate (2 × 20 mL). The organic layers were combined and evaporated under reduced pressure to give 1-(4-bromophenoxy)cyclopropane-1-carboxylic acid (500 mg, 1.95 mmol, yield 61.6%) as a light brown solid. 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.40–7.32 (m, 2H), 6.85–6.81 (m, 2H), 1.69 (dd, J = 8.4, 5.3 Hz, 2H), 1.38 (dd, J = 8.6, 5.1 Hz, 2H); LCMS (M⁻¹): 257.9. Step 4: Preparation of (Z)-2-(5-(5-(1-(4-bromophenoxy)cyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate Methyl methoxyacrylate (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 4-bromophenoxycyclopropane-1-carboxylic acid were used as starting materials. The synthesis method of methyl methoxyacrylate (2Z)-2-(5-(5-(1-(4-bromophenoxy)cyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate was the same as that described in Example 2. 1 H-NMR(400 MHz, chloroform-D) δ 7.58 (dd, J = 7.6, 1.5 Hz, 1H), 7.38-7.33 (m, 4H), 7.24(d, J = 7.8 Hz, 1H), 6.88-6.84 (m, 2H), 3.85 (s, 3H), 3.74 (d, J = 9.3 Hz, 1H), 3.69 (s, 4H), 2.39 (s, 3H), 1.82 (dd, J = 8.7, 5.5 Hz, 2H). Example 12: Preparation of (Z)-2-(5-(5-((3-bromophenoxy)difluoromethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate

[0322] Step 1: Preparation of 2-(3-bromophenoxy)-2,2-difluoroacetic acid

[0323] Under nitrogen protection, sodium hydride (0.25 g, 6.36 mmol) was added in portions to a stirred suspension of 3-bromophenol (1.0 g, 5.8 mmol) in 1,4-dioxane (20 mL) at 0°C. The resulting brown reaction mixture was then stirred at 25°C for 0.5 h, followed by the addition of a 10.00 mL solution of sodium 2-bromo-2,2-difluoroacetate (1.25 g, 6.36 mmol) in 1,4-dioxane. The resulting reaction mixture was stirred at 70°C for 1 h. The reaction mixture was cooled to 25°C, poured into ice water (30 mL), acidified with 3M HCl, and extracted with ethyl acetate (3 × 20 mL). The organic layers were combined, washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to obtain an oily residue. This residue was purified by rapid column chromatography to give 2-(3-bromophenoxy)-2,2-difluoroacetic acid (0.8 g, 3.00 mmol, yield 52%). LCMS (M-1): 266.75.

[0324] Step 2: Preparation of (Z)-2-(5-(5-((3-bromophenoxy)difluoromethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate Methyl methoxyacrylate (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 2-(3-bromophenoxy)-2,2-difluoroacetic acid were used as starting materials. The synthesis method of methyl methoxyacrylate (2Z)-2-(5-(5-((3-bromophenoxy)difluoromethyl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate was the same as that described in Example 2. 1 H-NMR (400 MHz, chloroform-D) δ 7.70 (dd, J = 7.7, 1.6 Hz, 1H), 7.51 (s, 1H),7.47-7.45 (m, 1H), 7.43 (d, J = 1.7 Hz, 1H), 7.38 (s, 1H), 7.31-7.28 (m, 3H), 3.90 (s, 3H), 3.72 (s, 3H), 2.43 (s, 3H); LCMS (M+1): 512.95. Example 13: (Z)-2-(5-(5-(1-cyclopropyl-5-methyl-1H-pyrazole-4-yl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate

[0325] Step 1: Preparation of ethyl 1-cyclopropyl-5-methyl-1H-pyrazole-4-carboxylate

[0326] To a stirred solution of ethyl 2-(ethoxymethylene)-3-oxobutyrate (15 g, 81 mmol) in ethanol (80 mL), 1-cyclopropylhydrazine hydrochloride (7.95 g, 73.2 mmol) was added, and the resulting reaction mixture was stirred at 73°C for 16 hours. After the reaction was complete, the reaction mixture was evaporated under reduced pressure, diluted with water (50 mL), and extracted with ethyl acetate (2 × 100 mL). The combined organic layers were washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to give ethyl 1-cyclopropyl-5-methyl-1H-pyrazole-4-carboxylic acid (11.8 g, 60.8 mmol, 83% yield) as a brown oil. 1 ¹H-NMR (400 MHz, chloroform-D) δ 7.78 (s, 1H), 4.30–4.25 (m, 2H), 3.37–3.32 (m, 1H), 2.63 (d, J = 4.3 Hz, 3H), 1.34 (td, J = 7.3, 5.0 Hz, 3H), 1.20–1.15 (m, 2H), 1.13–1.06 (m, 2H); LCMS (M+1): 194.3 Step 2: 1-Cyclopropyl-5-methyl-1H-pyrazole-4-carboxylic acid

[0327] An aqueous solution (25.00 mL) of sodium hydroxide (4.86 g, 122 mmol) was added to a stirred solution of ethyl 1-cyclopropyl-5-methyl-1H-pyrazole-4-carboxylic acid (11.8 g, 60.8 mmol) in 1,4-dioxane (25 mL) and ethanol (25 mL), and the resulting reaction mixture was stirred at 25°C for 16 hours. After the reaction was complete, the reaction mixture was evaporated under reduced pressure to give an oily residue, which was diluted with water (10 mL) and acidified to pH 4-5 with 1N HCl. The resulting precipitate was filtered and dried to give the target product, 1-cyclopropyl-5-methyl-1H-pyrazole-4-carboxylic acid (6.8 g, 40.9 mmol, yield 67.4%), as a white solid. 1H-NMR (400 MHz, DMSO-d6) δ 12.19 (s, 1H), 7.64 (s, 1H), 3.56-3.51 (m, 1H), 2.54 (s, 3H), 1.06-0.96 (m, 4H); LCMS (M+1) : 166.18. Step 3: (Z)-2-(5-(5-(1-cyclopropyl-5-methyl-1H-pyrazole-4-yl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate At 0°C, oxalyl chloride (0.66 mL, 6 mmol) was slowly added to a stirred solution of 1-cyclopropyl-5-methyl-1H-pyrazole-4-carboxylic acid (215 mg, 1.2 mmol) in dichloromethane (4 mL), followed by the addition of a catalytic amount. N,N - Dimethylformamide (2-3 drops). The resulting reaction mixture was stirred at 25°C for 4 hours. After the reaction was complete, the reaction mixture was concentrated under reduced pressure to give 1-cyclopropyl-5-methyl-1H-pyrazole-4-carbonyl chloride.

[0328] At 0°C, pyridine (0.260 mL, 3.21 mmol) was added to a stirred solution of (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate (300 mg, 1.07 mmol) in toluene (10 mL), followed by dropwise addition of a toluene solution (15 mL) of 1-cyclopropyl-5-methyl-1H-pyrazole-4-carbonyl chloride (237 mg, 1.28 mmol). The resulting reaction mixture was stirred at 100°C for 16 hours. After the reaction was complete, the reaction mixture was quenched with water (10 mL) and extracted with ethyl acetate (2 × 20 mL). The organic layers were combined, washed with saturated brine (20 mL), dried over anhydrous sodium sulfate, filtered, and evaporated under reduced pressure to obtain an oily residue. The residue was purified by rapid column chromatography to give (Z)-2-(5-(5-(1-cyclopropyl-5-methyl-1H-pyrazol-4-yl)-1,2,4-oxadiazol-3-yl)-2-methylphenoxy)-3-methoxyacrylate (140 mg, 0.341 mmol, yield 31.9%) as a pale yellow solid. 1H-NMR (400 MHz, chloroform-D) δ 8.00 (s,1H), 7.71 (dd, J = 7.6, 1.5 Hz, 1H), 7.47 (d, J = 1.5 Hz, 1H), 7.37 (s, 1H),7.28 (d, J = 8.3 Hz, 1H), 3.88 (s, J = 7.5 Hz, 3H), 3.70 (s, J = 15.0 Hz, 3H), 3.46-3.40 (m, 1H), 2.77 (s, J = 14.7 Hz, 3H), 2.33 (s, J = 15.0 Hz, 3H), 1.28-1.21 (m, 2H), 1.20-1.12 (m, 2H); LCMS (M+1): 411.10. Example 14: Preparation of (Z)-3-methoxy-2-(2-methyl-5-(5-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-1,2,4-oxadiazol-3-yl)phenoxy)methyl acrylate

[0329] Methyl methoxyacrylate (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 2-(5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)acetic acid were used as starting materials. The synthesis method of (Z)-3-methoxy-2-(2-methyl-5-(5-((5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)methyl)-1,2,4-oxadiazol-3-yl)phenoxy)acrylate was the same as that described in Example 2. 1 H-NMR (400 MHz, DMSO-d6) δ 7.65 (s, 1H), 7.52(dd, J = 7.6, 1.5 Hz, 1H), 7.38 (d, J = 7.8 Hz, 1H), 7.21 (d, J = 1.5 Hz,1H), 6.64 (s, 1H), 5.94 (s, 2H), 3.86 (s, 3H), 3.64 (s, 3H), 2.38 (s, 3H), 2.29 (s, 3H); LCMS (M-1) : 450.95. Example 15: Preparation of (Z)-3-methoxy-2-(2-methyl-5-(5-((2-oxo-3-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-1,2,4-oxadiazol-3-yl)phenoxy)methyl acrylate

[0330] Methyl methoxyacrylate (2Z)-2-(5-(N'-hydroxycarbamoyl)-2-methylphenoxy)-3-methoxyacrylate and 2-(2-oxo-3-(trifluoromethyl)pyridin-1(2H)-yl)acetic acid were used as starting materials. The synthesis method of (Z)-3-methoxy-2-(2-methyl-5-(5-((2-oxo-3-(trifluoromethyl)pyridin-1(2H)-yl)methyl)-1,2,4-oxadiazol-3-yl)phenoxy)acrylate was the same as that described in Example 2.

[0331] 1 H-NMR (400 MHz, DMSO-D6) δ 8.22 (dd, J = 6.8, 1.7 Hz, 1H), 8.09-8.07(m, 1H), 7.63 (s, 1H), 7.50 (dd, J = 7.7, 1.6 Hz, 1H), 7.37 (d, J = 8.1 Hz,1H), 7.19 (d, J = 1.5 Hz, 1H), 6.53 (t, J = 7.0 Hz, 1H), 5.57 (s, 2H), 3.85(s, 3H), 3.63 (s, 3H), 2.29 (s, 3H); LCMS (M+1): 465.9. Therefore, the compounds of the present invention are listed in Table 1 below in a non-limiting manner. In the following examples, M+1 (or M-1) represents the molecular ion peak observed in mass spectrometry plus or minus 1 atomic mass unit (amu).

[0332] Unless otherwise stated, all 1 All H NMR experimental results are reported in parts per million (ppm), and the signal of residual deuterated solvent is used as an internal standard for measurement.

[0333] The following compounds of the present invention (Table 1) were obtained using steps similar to those described in the schemes or examples.

[0334] Table 1

[0335] *The compound names were all generated using Chemdraw Professional 19.1 software Biological Examples As described herein, compounds of formula (I) exhibit fungicidal activity against a variety of plant pathogenic fungi that invade important crops. The methods for evaluating the activity of the compounds of this invention are as described in the following experiments: In vitro experiments Example 1: Rice blast fungus ( Pyricularia oryza )(rice blast): The compound was dissolved in 0.3% dimethyl sulfoxide solution, and then potato dextrose agar medium was added before dispensing into Petri dishes. 5 mL of the medium containing the desired test concentration of the compound was dispensed into sterile Petri dishes with a diameter of 60 mm. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of a Petri dish containing a virulent, rapidly growing rice blast fungus and inoculated into each dish. The Petri dishes were incubated at 25°C and 60% relative humidity for 7 days. Colony radial growth was measured and compared with that of an untreated control group. In these tests, compared with the untreated control group (which showed extensive pathogen growth), compounds 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 15, 16, 18, 19, 20, 21, 22, 24, 25, 26, 27, 31, 32, 33, 34, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, and 77 showed significantly higher efficacy. 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 112, 113, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 171, 172, 173, 174, 175, 176, 187, 188, 189, 190, 191, 193, 194, 195, 196, 199, 2 00, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 231, 232, 233, 234, 235, 237, 238, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 265266、267、268、269、270、271、272、273、274、275、276、277、278、279、280、281、282、283、284、285、286、287、288、289、290、291、292、293、294、295、296、297、298、300、301、302、303、304、305、306、307、308、309、310、311、312、313、314、315、316、317、318、319、320、321、322、323、324、325、326、327、328、329、330、331、332、333、334、335、336、337、339、340、341、342、343、344、345、346、348、349、350、352、353、354、355、356、357、358、359、360、361、362、363、364、365、367、368、369、370、371、372、373、374、375、376、377、378、379、380、381、382、383、384、385、386、387、388、389、390、391、392、393、409、410、411、412、413、414、415、416、417、418、419、420、421、422、423、424、425、426、427、428、429、430、431、432、433、434、435、436、437、438、439、440、441、442、443、444、445、446、447、448、449、450、451、452、453、454、455、456、457、458、459、460、461、462、463、464、465、466、467、468、469、470、471、472、473、474、475、476、477、478、479、480、481、482、483、484、485、486、487、488、489、490、491、492、493、494、495、496、497、498、499、500、501、502、503、504、505、506、507、508、509、510、511、512、513、514、515、516、517、518、519、520、521、522、523、524、525、526、527、528、529、530、531、532、533、534、535、536、537、538、539、540、541、542、543、544、545、546、547、548、549、550、551、552、553、555、556、557、558、559、560、561、562、563、564、565、566、567、568、569、570、571、572、574、576、577、579、580、581、582、583、584、585、586、587、589、590、591、592、593、594、595、596、600、601、602、603、604、605、606、607、608、609、610、611、612、613、614、615、616、617、618、619、620、621、622、623、624、625、626、627、628、629、630、631、632、633、634、635、636、637、638、639、640、641、642、643、644、645、646、647、648、649、650、651、652、653、654、655、656、657、658、659、660、661、662、663、664、665、666、667、668、669、670、672、673、674、676、677、678、679、680、681、682、683、684、685、686、687、688、689、690、691、692、693、694、695、696、697、698、699、700、702、703、704、705、706、707、709、710、713、714、716、722、723、725、727、728、729、730、731、732、733、734、735、736、737、738、739、740、741、742、743、744、745、747、749、750、762、764、771、772、773、774、775、776、778、780、781、782、783、784、785、787、789、790、791、792、793、794、795、796、797、798、799、800、801、802、803、804、805、806、807、808、810、812、820、827、828、829、830、831、832、833、834、835、836、837、838、839、840、841、842、844、845、846、847、The control rates of molecules 848, 849, 850, 851, 852, 853, 854, 855, 856, 857, 861, 862, 864, 866, 867, 868, 869, 870, 871, 872, 873, 874, 875, 876, 877, and 878 at 300 ppm reached 70% or higher.

[0336] Example 2: Alternaria solanacearum ( Alternaria solani (Early blight of tomato / potato): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then added to potato dextrose agar medium before dispensing into petri dishes. 5 mL of the medium containing the desired concentration of the compound was dispensed into sterile petri dishes with a diameter of 60 mm. After the medium solidified, 5 mm diameter mycelial fragments were taken from the edge of a petri dish containing a virulent *Alternaria solanacearum* fungus and inoculated into each dish. The petri dishes were incubated at 25°C and 60% relative humidity for 7 days. Colony radial growth was measured and compared with that of an untreated control group. In these tests, compared with the untreated control group (which showed extensive pathogen growth), compounds 2, 3, 5, 6, 8, 9, 12, 15, 16, 18, 19, 21, 22, 24, 25, 26, 32, 33, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 67, 68, 69, 70, 72, 74, 75, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 96, 97, 99, 100, 101, 102, 104, 105, 106, 107, 108, 110, 113, 114, 115, 116, 117, 118, 119, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 142, 144, 146, 147, 148, 151, 154, 155, 156, 158, 160, 161, 166, 194, 195 196, 197, 199, 200, 202, 203, 204, 211, 212, 213, 214, 215, 216, 217, 231, 232, 234, 235, 237, 242, 245, 250, 252, 255, 261, 262, 265, 266, 267, 269, 270, 271, 272, 273, 274, 276, 277, 278, 279, 280, 281, 282, 284, 285, 286, 287, 291, 292, 294, 295, 2 96, 297, 298, 300, 302, 303, 304, 312, 313, 315, 316, 317, 318, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 331, 332, 333, 334, 339, 344, 346, 347, 348, 349, 350, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 367, 368369、370、371、372、373、374、375、376、378、379、380、381、382、383、384、386、387、389、390、391、392、393、409、410、411、412、413、414、415、416、417、418、419、420、424、425、426、427、428、429、430、431、432、433、434、435、436、437、438、439、440、441、442、443、444、445、446、447、448、449、450、451、452、453、454、457、458、459、462、463、464、465、466、467、470、471、472、473、474、475、476、477、478、479、481、483、484、485、486、487、488、489、490、491、492、493、494、495、496、497、498、499、500、501、502、503、504、505、506、507、508、509、510、511、512、513、514、515、517、518、519、521、522、523、524、525、526、527、528、529、531、532、533、534、535、536、537、538、539、541、543、544、545、546、547、548、549、550、551、552、553、555、556、557、558、559、560、561、562、563、564、565、566、567、568、569、570、571、572、573、574、575、576、577、579、580、581、582、583、584、585、587、589、590、591、593、594、596、600、601、602、603、604、605、606、607、608、609、611、614、615、616、617、619、620、621、622、623、624、625、626、627、628、629、630、631、632、633、634、635、636、637、639、640、641、642、646、647、648、649、650、651、652、653、660、661、662、663、664、665、666、667、668、669、670、671、672、673、674、676、The control rates of compounds 677, 678, 680, 681, 682, 683, 684, 685, 686, 687, 688, 689, 690, 691, 692, 694, 695, 696, 697, 704, 722, 724, 727, 728, 795, and 805 at 300 ppm reached 70% or higher.

[0337] Example 3: Anthracnose of the pepper ( Colletotrichum capsici )(anthrax): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then added to potato dextrose agar medium before dispensing into petri dishes. Five mL of the medium containing the desired concentration of the compound was dispensed into sterile 60 mm diameter petri dishes. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of a vigorous anthracnose fungus petri dish and inoculated into each dish. The petri dishes were incubated at 25°C and 60% relative humidity for 7 days. Colony radial growth was measured and compared with an untreated control group.In these tests, compared with the untreated control group (which showed extensive pathogen growth), compounds 3, 46, 47, 48, 49, 50, 51, 54, 56, 59, 60, 69, 70, 72, 73, 77, 79, 80, 82, 87, 94, 100, 101, 102, 103, 104, 106, 107, 118, 128, 129, 134, 139, 142, 145, 155, 166, 195, 196, 199, 204, 212, 213, 214, 216, 217, 263, 278, 279, 281, and 284... 285, 286, 288, 289, 291, 292, 293, 294, 295, 296, 298, 313, 317, 321, 325, 326, 327, 328, 329, 332, 334, 335, 341, 343, 346, 348, 349, 350, 352, 353, 354, 355, 356, 357, 358, 359, 360, 362, 374, 379, 381, 382, ​​384, 386, 387, 390, 392, 393, 409, 411, 413, 415, 418, 424, 4 29, 430, 431, 432, 433, 436, 437, 441, 442, 443, 444, 445, 446, 447, 448, 449, 450, 451, 452, 453, 466, 471, 472, 475, 481, 485, 486, 493, 494, 495, 496, 497, 498, 499, 501, 503, 504, 505, 507, 508, 512, 513, 514, 515, 517, 518, 521, 526, 527, 531, 532, 535, 543, 544, 54 6, 549, 550, 551, 552, 555, 556, 557, 558, 559, 560, 562, 563, 564, 565, 566, 568, 571, 576, 581, 583, 584, 585, 587, 600, 601, 603, 604, 605, 606, 607, 611, 619, 620, 623, 624, 625, 626, 628, 629, 630, 631, 632, 633, 635, 636, 641, 642, 646, 648, 662, 684, 696, and 704 achieved control rates of 70% or higher at 300 ppm.

[0338] Example 4: Tomato leaf spot pathogen ( Corynespora cassiicola (Tomato leaf spot disease): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then added to potato dextrose agar medium before dispensing into petri dishes. Five mL of the medium containing the desired concentration of the compound was dispensed into sterile 60 mm diameter petri dishes. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of the petri dish containing a virulent tomato leaf spot pathogen and inoculated into each dish. The petri dishes were incubated at 25°C and 70% relative humidity for 7 days. Colony radial growth was measured and compared with the untreated control group.

[0339] In these tests, compounds 141819101106110282350498499505507564603 and 611 achieved control rates of 70% or higher at 300 ppm compared to the untreated control group (which exhibited extensive pathogen growth).

[0340] Example 5: Phytophthora infestans ( Phytophthora infestans (Last blight of potatoes and tomatoes): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then rye agar medium was added before dispensing into Petri dishes. Five mL of the medium containing the desired test concentration of the compound was dispensed into sterile Petri dishes with a diameter of 60 mm. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of the Petri dish containing a vigorous pathogenic *Phytophthora* and inoculated into each dish. The Petri dishes were incubated at 18°C ​​and 95% relative humidity for 7 days. Colony radial growth was measured and compared with that of an untreated control group. In these tests, compared with the untreated control group (which showed extensive pathogen growth), compounds 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 15, 16, 18, 19, 20, 21, 22, 24, 25, 26, 31, 32, 33, 34, 35, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 63, 67, 69, 70, 71, 72, 73, 74, 75, 76, 78, 79, 80, 81, 82, 83, 84, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 100, 101, 102, 103, 104, 105, 106, 107, 108, 110, 111, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 138, 139, 140, 141, 142, 143, 144, 1 45, 146, 147, 148, 149, 150, 152, 153, 154, 157, 161, 162, 163, 166, 167, 168, 169, 170, 171, 174, 175, 186, 187, 189, 190, 191, 193, 194, 195, 196, 197, 199, 200, 201, 202, 203, 204, 205, 207, 209, 211, 212, 213, 214, 215, 231, 234, 237, 238, 239, 243 246, 250, 251, 252, 253, 255, 256, 258, 259, 261, 262, 265, 266, 267, 268, 269, 270, 271, 272, 273, 274, 276, 277, 278, 279, 281, 282, 283, 284, 285, 286, 288, 289, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 301, 302, 303, 304, 306, 309, 312313、315、316、317、318、324、325、326、327、329、330、331、334、349、350、352、353、354、355、356、357、358、359、360、361、362、363、364、367、368、369、370、372、373、374、375、376、377、378、379、380、381、382、383、384、385、386、388、389、390、392、393、409、410、411、412、413、414、415、416、417、418、420、421、423、424、425、427、428、429、430、431、432、433、435、436、437、438、439、440、441、442、445、446、447、449、450、451、452、453、454、455、456、457、458、459、460、461、463、464、465、466、467、468、469、471、472、473、474、475、477、478、479、480、481、483、484、485、486、487、488、489、490、491、492、493、494、495、496、497、498、499、501、502、503、505、506、507、508、511、512、513、514、515、516、517、518、519、520、521、522、523、524、525、526、527、529、531、532、535、536、540、541、543、544、545、546、547、548、549、550、551、552、553、554、555、556、557、558、559、560、561、562、563、564、565、566、567、570、571、573、574、575、577、580、581、583、584、585、586、587、589、590、591、592、593、594、595、596、600、601、602、603、604、605、606、607、609、610、611、612、615、616、617、618、619、620、621、622、623、624、625、626、627、628、629、630、631、632、633、634、635、636、637、640、641、642、643、644、645、646, 647, 648, 649, 650, 651, 652, 653, 655, 656, 657, 658, 659, 660, 661, 662, 663, 664, 665, 666, 667, 668, 669, 670, 671, 672, 673, 674, 675, 676, 677, 678, 680, 681, 682, 683, 684, 685, 688, 689, 690, 691, 692, 693 The following substances achieved a control rate of 70% or higher at 300 ppm: 695, 696, 697, 698, 700, 701, 703, 704, 705, 706, 707, 713, 722, 728, 736, 780, 786, 788, 791, 794, 795, 798, 800, 802, 804, 810, 812, 821, 822, 824, 825, 831, 832, 834, 835, 848, 864, 866, 868, 870, 874, 875, and 876.

[0341] Example 6: Botrytis cinerea ( Botrytis cinerea (Gray mold): Liquid test Preparation containing Botrytis cinerea (BOTRCI, 10) 4 Yeast, bacterial peptone, and sodium acetate (YBA) liquid medium containing spore suspensions (spores / mL). In inhibition assays, each test compound was dissolved in dimethyl sulfoxide (DMSO), and 100 µL of the corresponding test solution was added to each well of a 96-well microplate. An equal volume (100 µL) of medium and spore suspension was then added to each well to obtain the final test concentration. The microplates were incubated at 22°C for 15–18 days. Growth inhibition was assessed by measuring the OD600 value. The inhibition rate was calculated using the following formula: I = (CB) - (TB) / (CB) * 100 Where T = treatment group, C = control group, and B = blank group. In these tests, compounds 155156157158166168489507512567574603604632635662666 and 696 achieved control rates of 70% or higher at 300 ppm compared to the untreated control group (which exhibited extensive pathogen growth).

[0342] Example 7: Fusarium ( Fusarium culmorum (Root rot / ear rot in cereal crops): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then added to potato dextrose agar medium before dispensing into petri dishes. 5 mL of the medium containing the desired concentration of the compound was dispensed into 60 mm sterile petri dishes. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of a vigorous, highly virulent bacterial culture dish and inoculated into each dish. The dishes were incubated at 25°C and 60% relative humidity for 7 days. Colony radial growth was measured and compared with that of an untreated control group.

[0343] In these tests, compounds 139272273274291409410489498504507521565566572662 and 666 achieved control rates of 70% or higher at 300 ppm, compared to the untreated control group (which exhibited extensive pathogen growth).

[0344] Example 8: Sclerotinia sclerotiorum ( Sclerotinia sclerotiorum (White mold): The compound was dissolved in a 0.3% dimethyl sulfoxide solution, and then added to potato dextrose agar medium before dispensing into petri dishes. Five mL of the medium containing the desired test concentration of the compound was dispensed into 60 mm sterile petri dishes. After the medium solidified, a 5 mm mycelial fragment was taken from the edge of the vigorous, highly virulent bacterial culture dish and inoculated into each dish. The dishes were incubated at 20°C and 70% relative humidity for 7 days. Colony radial growth was measured and compared with that of an untreated control group.

[0345] In these tests, compounds 46475254577072118121129133135151152155171261262273294307317350358450484486489495512514518532566600603604605607635662 and 666 achieved control rates of 70% or higher at 300 ppm, compared to the untreated control group (which exhibited extensive pathogen growth).

[0346] Greenhouse Experiment: Example A: Rice blast fungus ( Pyriculariaoryzae )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0347] To test the preventative activity of the compound, healthy rice seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle inside a spray box. One day after treatment, a solution containing 1.4 × 10⁻⁶ ppm was applied. 6 The plants were inoculated with a spore suspension of rice blast fungus. The inoculated plants were then placed in a greenhouse at 24°C and 95% relative humidity to observe disease symptoms.

[0348] The performance of the compound was evaluated by visually assessing the severity of disease in treated plants (0-100%) at 3, 7, 10, and 15 days after application. The efficacy (control rate %) of the compound was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the plant compatibility of the compound was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 1, 5, 14, 15, 21, 35, 47, 51, 69, 70, 72, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 91, 96, 101, 109, 110, 111, 112, 114, 118, 119, 122, 129, 138, 150, 152, 153, 160, 161, 169, 173, and 176 showed significantly higher efficacy. 177, 178, 182, 183, 187, 188, 191, 192, 194, 198, 204, 213, 231, 233, 234, 235, 243, 244, 269, 271, 272, 309, 313, 315, 316, 317, 324, 325, 337, 338, 368, 369, 371, 375, 378, 379, 381, 382, ​​383, 384, 385, 386, 387, 388, 389, 390 391, 392, 393, 409, 413, 416, 417, 418, 420, 422, 423, 424, 425, 426, 427, 428, 433, 435, 437, 438, 439, 441, 444, 445, 446, 447, 450, 453, 454, 457, 467, 468, 474, 475, 479, 480, 481, 482, 483, 484, 487, 488, 489, 491, 492, 493 The following substances achieved a control rate of 70% or higher at 500 ppm: 494, 497, 554, 555, 557, 560, 562, 563, 564, 565, 566, 573, 575, 577, 584, 585, 587, 588, 589, 591, 594, 595, 612, 613, 614, 630, 637, 669, 670, 707, 710, 713, 714, 732, 733, 734, 735, 736, 737, 738, 740, 741, 762, 770, and 771.

[0349] Example B: Alternaria alternata on tomatoes ( Alternaria solani )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0350] To test the preventative activity of the compound, healthy tomato seedlings grown in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle inside a spray box. One day after treatment, a solution containing 0.24 × 10⁻⁶ was applied. 6 Plants were inoculated with a spore suspension of Alternaria alternata and 2% malt. The inoculated plants were then placed in a greenhouse at a temperature of 22-24°C and a relative humidity of 90-95% to observe disease symptoms.

[0351] The performance of the compound was evaluated by visually assessing the severity of disease in treated plants (0-100%) at 3, 7, 10, and 15 days after application. The efficacy (control rate %) of the compound was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the plant compatibility of the compound was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 2, 3, 4, 5, 8, 9, 11, 14, 15, 20, 21, 51, 54, 56, 57, 58, 60, 63, 64, 65, 67, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 88, 97, 99, 100, 102, 103, 104, 113, 114, 117, 118, 119, 122, 123, 128, 129, 133, 139, 143, 144, 146, 147, 152, 153, and 1 54, 155, 157, 159, 160, 161, 162, 163, 164, 165, 167, 169, 170, 171, 172, 174, 176, 177, 178, 179, 180, 182, 183, 184, 194, 195, 196, 197, 198, 203, 205, 207, 208, 209, 211, 212, 213, 214, 217, 220, 230, 237, 244, 250, 252, 253, 259, 262, 267, 275, 276, 277, 284, 294, 30 8, 309, 310, 311, 312, 313, 323, 324, 325, 326, 327, 328, 333, 334, 335, 337, 340, 341, 343, 344, 345, 346, 347, 348, 349, 368, 371, 372, 374, 375, 376, 377, 378, 379, 382, ​​383, 387, 415, 416, 417, 418, 419, 421, 422, 423, 424, 425, 426, 428, 429, 431, 432, 433, 435, 436 437, 438, 439, 441, 442, 443, 444, 446, 447, 449, 450, 452, 454, 463, 472, 555, 556, 557, 558, 559, 560, 561, 562, 563, 564, 565, 566, 570, 571, 581, 582, 583, 584, 585, 598, 602, 610, 612, 613, 614, 622, 623, 627, 630, 631, 632, 637, 638, 641, 643, 644, 645, 646, 647The control rates of 648, 655, 656, 657, 671, 672, 673, 674, 676, 677, 678, 704, 709, 710, 713, 717, 718, 719, 720, 721, 722, 724, 732, 733, 736, 742, 745, 746, 760, 761, 762, 763, 765, 766, 768, 770, and 771 at 500 ppm reached 70% or higher.

[0352] Example C: Soybean root rot pathogen ( Phakopsora pachyrhizi )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0353] To test the preventative activity of the compound, healthy soybean seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle in a spray box. One day after treatment, a solution containing 2×10⁻⁶ mg / L was applied. 5 Plants were inoculated with a suspension of conidia of the root rot fungus. The inoculated plants were then placed in a greenhouse at a temperature of 22-24°C and a relative humidity of 80-90% to observe the disease manifestations.

[0354] On days 3, 7, 10, and 15 post-application, the severity of disease in treated plants was visually assessed and graded (0-100%) to evaluate the compound's performance. The efficacy (control rate %) of the compound and combination was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the compatibility of the compound with the plant was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 1, 2, 3, 4, 5, 8, 9, 10, 11, 12, 13, 14, 15, 16, 18, 19, 20, 21, 24, 25, 26, 27, 28, 32, 33, 34, 35, 36, 46, 47, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 8 3, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 97, 99, 100, 101, 102, 103, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 118, 119, 120, 121, 123, 126, 127, 128, 129, 130, 132, 133, 134, 138, 139, 144, 147, 149, 150, 151, 152, 153, 154, 155, 157, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 174, 177, 178, 179, 180, 182, 183, 184, 185, 187, 188, 189, 190, 191, 192, 193, 194, 195, 196, 197, 198, 200, 201, 202, 204, 205, 206, 207, 208, 209, 212, 213, 214, 218, 219, 220, 221, 222, 230, 231, 232, 233, 234, 235, 237, 238, 243 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 255, 256, 257, 258, 259, 260, 261, 262, 266, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 291, 293, 294, 295, 296, 297, 300, 306, 307, 308, 309, 311312、313、314、315、316、317、318、319、321、324、325、326、327、328、334、335、337、338、339、340、341、342、343、344、345、346、347、348、349、350、351、367、368、369、370、371、372、373、374、375、376、377、378、379、380、381、382、383、384、385、386、387、388、389、390、392、393、395、397、398、400、406、409、410、411、413、414、415、431、432、433、434、435、436、437、438、439、440、441、442、443、444、445、446、447、448、449、450、451、452、453、454、455、456、457、458、459、460、461、462、463、464、467、472、473、474、475、477、478、479、480、481、483、484、485、486、487、489、490、491、492、493、494、495、497、498、499、555、557、558、559、560、561、562、564、565、566、567、575、576、583、584、585、587、589、592、595、599、602、603、606、610、612、613、614、615、616、617、618、620、621、622、623、624、625、626、627、630、631、632、633、634、635、636、637、638、639、641、642、643、644、645、646、647、648、655、656、657、661、662、663、664、665、667、668、669、670、672、673、674、675、676、677、678、679、684、690、691、700、701、702、703、704、706、707、709、710、727、730、732、733、734、736、738、739、740、741、742、743、744、745、746、758、761、762、763、764、765、766、768、770、771、773、774、776、778、779、780、781、782、Electrolytes 835, 841, 845, 846, and 851 achieved control rates of 70% or higher at 500 ppm.

[0355] Example D: Wheat glume blight pathogen in wheat ( Parastagonospora nodorum ) / Syndromea oryzae ( Septoria nodorum Cryptosporidium wheatii ( ) / Cryptococcus Stagnospora nodorum ) experiment Dissolve the compound in a 2% dimethyl sulfoxide / acetone solution, then mix with water containing the emulsifier to prepare a 30 mL spray solution. Pour the spray solution into a spray bottle for subsequent application.

[0356] To test the preventative activity of the compound, healthy wheat seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle in a spray box. One day after treatment, a solution containing 2.8 × 10⁻⁶ mg / L was applied. 6 Plants were inoculated with a suspension of *Clostridium clavatum*. The inoculated plants were then placed in a greenhouse at 22-25°C and 90-100% relative humidity to observe disease symptoms.

[0357] At 3, 7, and 10 days after application, the performance of the compound was evaluated by visually assessing the severity of disease in treated plants (0-100%). The efficacy (control rate %) of the compound was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the plant compatibility of the compound was assessed by recording symptoms such as necrosis, yellowing, and stunting.

[0358] In these trials, compounds 1815207596114117118133139140141142143145147161162163166167170177178179180182183191196197198200203213214267307308313490491496497602603622623635637671673742743744745746 and 747 achieved control rates of 70% or higher at 500 ppm, compared to the untreated control group (which exhibited extensive disease development).

[0359] Example E: Botrytis cinerea (Tomato gray mold) Botrytis cinere )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0360] To test the preventative activity of the compound, healthy tomato seedlings grown in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle in a spray box. One day after treatment, a solution containing 1.2 × 10⁻⁶ was applied. 6 Plants were inoculated with a spore suspension of gray mold and 2% malt. The inoculated plants were then placed in a greenhouse at a temperature of 18-20°C and a relative humidity of 90-100% to observe disease symptoms.

[0361] At 3, 7, and 10 days after application, the performance of the compound was evaluated by visually assessing the severity of disease in treated plants (0-100%). The efficacy (control rate %) of the compound was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the plant compatibility of the compound was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 32, 36, 71, 75, 78, 97, 98, 99, 103, 104, 113, 114, 117, 121, 122, 123, 129, 133, 147, 159, 160, 161, 162, 163, 166, 167, 169, 170, 182, 183, 184, 186, 195, 197, 204, 205, 206, 207, 208, 210, 211, 218, 219, 220, and 221 showed significantly higher efficacy. The following substances achieved a control rate of 70% or higher at 500 ppm: 230, 269, 281, 286, 287, 288, 320, 340, 348, 349, 409, 415, 422, 471, 473, 474, 475, 476, 477, 483, 484, 489, 493, 495, 496, 497, 498, 499, 602, 603, 635, 636, 672, 673, 677, 701, 703, 724, 738, 742, 744, 745, 746, 754, 755, 756, 757, 758, 770, and 771.

[0362] Example F: Rhizoctonia solani (Rhizoctonia solani) Rhizoctonia solani )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0363] To test the preventive activity of the compound, healthy rice seedlings / plants cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle in a spray box.

[0364] One day after treatment, the plants were inoculated with an equal amount of rice bran containing Rhizoctonia solani. The inoculated plants were then placed in a greenhouse at a temperature of 24-25°C and a relative humidity of 90-95% to observe the disease manifestations.

[0365] The performance of the compounds was evaluated by visually assessing the severity of disease in treated plants (0-100%) at 3, 7, 10, and 15 days after application. The efficacy (control rate %) of the compounds was calculated by comparing the disease severity of the treated groups with that of one of the untreated inoculated control groups. Furthermore, plant compatibility of the compounds was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these trials, compounds 4117125126160161162165177178183190191193213214324328333335376431438439692701745746766 and 771 achieved control rates of 70% or higher at 500 ppm compared to the untreated control group (which exhibited widespread disease development).

[0366] Example G: Fusarium oxysporum ( Fusarium culmorum )test The compound was dissolved in a 2% dimethyl sulfoxide / acetone solution, and then mixed with water containing the emulsifier to prepare a 30 mL spray volume. The test solution was poured into a spray bottle for subsequent application.

[0367] To test the preventative activity of the compound, healthy wheat seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed dosage using a hollow cone nozzle inside a spray box. One day after treatment, a solution containing 2×10⁻⁶... 6 Plants were inoculated with a spore suspension of Fusarium and 2% malt. The inoculated plants were then placed in a greenhouse at 24°C and 80-90% relative humidity to observe disease symptoms.

[0368] The performance of the compound was evaluated by visually assessing the severity of disease in treated plants (0-100%) at 3, 7, 10, and 15 days after application. The efficacy (control rate %) of the compound was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the plant compatibility of the compound was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these trials, compounds 25356970102103114117143144145147151156158166167168171172190191193194196197203217281283286287288322334336337368409430444449452469481483484561564565573617641656673742743747 and 771 achieved control rates of 70% or higher at 500 ppm, compared to the untreated control group (which exhibited extensive disease development).

[0369] Example H: Pathogenic Phytophthora on tomato plants ( Phytophthora infestans )test Dissolve the compound in a 2% dimethyl sulfoxide / acetone solution, then mix with water containing the emulsifier to prepare the required test concentration. The spray volume is 30 mL. Pour the test solution into a spray bottle for subsequent application.

[0370] To test the preventative activity of the compound, healthy tomato seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed concentration using a hollow cone nozzle in a spray box. One day after treatment, a sporangium suspension (containing 0.24 × 10⁻⁶) was applied. 6 The plants were inoculated with cold, sterile water containing the pathogenic fungus *Phytophthora infestans*. After inoculation, the plants were cultured in a dark environment at 15°C for 24 hours, and then moved to a greenhouse at 18°C ​​and 95-100% relative humidity to observe the disease manifestations.

[0371] On days 3, 7, 10, and 15 post-application, the treated plants were visually assessed to classify the severity of disease (0-100%) to evaluate the compound's performance. The compound's efficacy (control rate %) was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the compound's plant compatibility was assessed by recording symptoms such as necrosis, yellowing, and stunting.In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 1, 2, 3, 4, 8, 9, 32, 60, 64, 65, 69, 70, 78, 79, 102, 109, 113, 114, 117, 119, 132, 140, 147, 152, 155, 156, 160, 161, 162, 163, 165, 167, 170, 171, 180, 184, 185, 187, 188, 190, 191, 194, 195, 197, 201, 203, 212, 213, 214, 217, 218, 221, 230, and 2 32, 234, 235, 237, 238, 241, 243, 244, 250, 251, 252, 255, 259, 262, 267, 268, 269, 270, 271, 272, 273, 274, 275, 276, 277, 286, 287, 288, 290, 293, 294, 300, 302, 303, 304, 306, 308, 309, 313, 316, 318, 319, 320, 324, 325, 326, 334, 337, 344, 346, 347, 348, 349, 368, 371, 372, 373 374, 375, 376, 378, 379, 380, 381, 382, ​​383, 384, 386, 387, 388, 389, 391, 392, 393, 412, 413, 414, 415, 425, 431, 435, 436, 437, 438, 439, 441, 443, 444, 445, 450, 451, 452, 454, 455, 456, 467, 468, 471, 472, 473, 477, 478, 480, 481, 483, 484, 485, 487, 488, 489, 491, 492, 493, 4 The control rates of 95, 557, 558, 559, 560, 562, 564, 565, 566, 571, 583, 584, 585, 587, 589, 599, 600, 602, 603, 610, 612, 613, 616, 617, 620, 621, 622, 624, 631, 637, 638, 645, 646, 648, 669, 670, 671, 672, 673, 678, 679, 690, 691, 692, 704, 717, 718, 719, 720, 753, 762, 771, 836, 839, 844, and 847 reached 70% or higher at 500 ppm.

[0372] Example 1: *Pseudomonas cucumeroides* on cucumber plants ( Pseudoperonospora cubensis ) Dissolve the compound in a 2% dimethyl sulfoxide / acetone solution, then mix with water containing the emulsifier to prepare the desired test concentration. The spray volume is 30 mL. Pour the test solution into a spray bottle for subsequent application.

[0373] To test the preventative activity of the compound, healthy cucumber seedlings cultivated in a greenhouse were sprayed with the active compound formulation at the prescribed concentration using a hollow cone nozzle in a spray box. One day after treatment, a solution containing 2×10⁻⁶... 4 Plants were inoculated with a spore suspension of *Pseudomonas columbinis*. The inoculated plants were then placed in a greenhouse at 23°C and 80-90% relative humidity to observe disease symptoms.

[0374] On days 3, 7, 10, and 15 post-application, the treated plants were visually assessed to classify the severity of disease (0-100%) to evaluate the compound's performance. The compound's efficacy (control rate %) was calculated by comparing the disease severity of the treated group with that of the untreated control group. Furthermore, the compound's plant compatibility was assessed by recording symptoms such as necrosis, yellowing, and stunting. In these experiments, compared with the untreated control group (which showed extensive disease development), compounds 1, 35, 50, 54, 57, 58, 59, 60, 63, 64, 69, 70, 71, 75, 78, 81, 87, 91, 93, 94, 95, 100, 102, 103, 106, 112, 113, 114, 118, 119, 123, 124, 125, 126, 128, 132, 133, 134, 142, 144, 149, 150, 151, 152, 154, 155, 157, and 160, 161, 162, 165, 171, 172, 175, 177, 178, 179, 183, 190, 191, 192, 193, 194, 195, 196, 197, 198, 204, 205, 212, 213, 214, 230, 237, 253, 255, 260, 261, 262, 266, 267, 269, 273, 274, 278, 279, 281, 282, 284, 285, 286, 287, 291, 293, 295, 300, 301, 302, 308 309, 310, 311, 312, 313, 314, 315, 316, 317, 318, 322, 326, 328, 335, 340, 346, 348, 350, 368, 369, 371, 372, 374, 375, 376, 378, 379, 410, 412, 413, 414, 415, 416, 418, 421, 423, 425, 426, 427, 428, 429, 430, 431, 437, 438, 439, 441, 445, 447, 448, 450 The following compounds achieved a control rate of 70% or higher at 500 ppm: 451, 454, 455, 456, 457, 474, 478, 480, 483, 485, 489, 491, 492, 493, 495, 556, 557, 559, 560, 565, 566, 569, 570, 583, 584, 585, 587, 588, 589, 599, 610, 616, 617, 618, 620, 630, 631, 632, 633, 634, 690, 691, 692, 700, 732, 735, 745, 754, 762, and 840.

[0375] Having described the invention with reference to certain preferred embodiments, other embodiments will become apparent to those skilled in the art upon reading the specification. Those skilled in the art will understand that many modifications can be made to the materials and methods without departing from the scope of the invention.

Claims

1. A compound of formula (I), or a salt, stereoisomer, polymorph, or N-oxide thereof: (I) in, A 1 Selected from NR A1 Or O; where R A1 Selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C3-C6 cycloalkyl, and C3-C6 cycloalkyl-C1-C3 alkyl; R 1 Selected from hydrogen, halogens, C1-C3 alkyl groups, C1-C3 haloalkyl groups, and C3-C6 cycloalkyl groups; R 2 Selected from hydrogen, halogens, methyl, and methoxy groups; R 3 Selected from hydrogen, halogens, C1-C3 alkyl groups, and C1-C3 alkoxy groups; R 4 Selected from the following groups: hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-ynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C3-C6-halocycloalkyl, C1-C6-alkoxy, C2-C6-alkenoxy, C2-C 6-Alkynoyl, C1-C6-Haloalkoxy, C3-C6-Cycloalkoxy, C1-C6-alkylthio, C1-C6-Haloalkylthio, Cyano-C1-C6-alkyl-, C3-C6-Cycloalkyl-C1-C6-alkyl-, C3-C6-Cycloalkyl-C2-C6-Alkenyl-, C3-C6-Cycloalkyl-C2-C4-Alkyno-, C1-C6-Alkoxy-C1-C6-alkyl-, -(CHR 3 ) 0-2 C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -NR 8 CONR 8 R 9 -NR 8 SO2R 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 -CON=SO(R 12 )-R 13 -CONR 8 SO2R 10 , phenyl, phenyl-C1-C6-alkyl-, phenoxy-C1-C3-alkyl-, naphthyl, C5-C 12 Saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocycles with C1-C3-alkyl groups, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl groups, 5- or 6-membered heteroaryl-C1-C3-alkyl groups, 5- to 10-membered heteroaryl oxy-C1-C3-alkyl groups, and 9- or 10-membered bicyclic heteroaryl-C1-C3-alkyl groups; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaromatic rings, and 8- to 10-membered bicyclic heteroaromatic rings contain 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b Substitution of 1 to 4 substituents; R 5 Selected from H or C1-C3 alkyl groups; or, R 5 and R A1 The N atom attached to it together forms a 5-6 membered non-aromatic heterocycle, which contains 1, 2 or 3 heteroatoms independently selected from N, O, S, S(O) or SO2, wherein 1 to 2 carbon atoms on the heterocycle may be substituted by C=O or C=S; the 5-6 membered heterocycle is either unsubstituted or substituted by 1 to 3 substituents independently selected from halogen, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy or C1-C6 haloalkoxy. R 6 Selected from hydrogen or C1-C6 alkyl; R 6a The group is selected from C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 alkoxy-C1-C3 alkyl, C1-C6 alkylthio-C1-C3 alkyl, C3-C6 cycloalkyl and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, trifluoromethyl, methoxy or ethoxy; R 7a Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C3-C6-cycloalkyl, C1-C6-alkoxy, C3-C6-cycloalkoxy, C1-C6-haloalkoxy, C1-C6-alkylthio, -NH-S(O)2-C1-C6-alkyl, -S(O)2-C1-C6-alkyl, -SR 9a , benzyloxy, pyrazolyl, pyridyl, phenyl, naphthyl, indene, phenylthio, C1-C6-haloalkylthio and C1-C6-alkylcarbonyl; wherein, the C3-C6 cycloalkyl, pyrazolyl, phenyl and phenylthio are not substituted, or are substituted by 1 to 3 identical or different substituents selected from chlorine, fluorine, bromine, methyl, ethyl, amino, trifluoromethyl, methoxy or ethoxy; R 7b Selected from halogens, cyano groups, NO2, -OH, and -N(R) 8 2. C1-C6-alkyl, C2-C6-alkenyl, C1-C6-cyanoalkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cyanocycloalkyl, C3-C6-cycloalkyl-C1-C3-alkyl, C1-C6-alkoxy, oxo, thio, C1-C6-haloalkoxy, C1-C6-alkylthio, C1-C6-haloalkylthio, phenyl, phenoxy, 4-6 membered non-aromatic heterocycles containing 1, 2 or 3 heteroatoms (independently selected from N, O or S), C1-C6-alkylcarbonyl, -SCF3, -S(O)2-R 9a -(CHR) 3 ) 0-2 C(R 6 )=NOR 11a -NR 8a R 9a -NR 8a COR 10a NR 8a CONR 8a R 9a -NR 8a SO2R 10a -(CHR) 3 ) 0-2 COR 9a -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 CONR 8a R 9a -CON=SO(R 12a )-R 13a and -CONR 8a SO2R 10a Wherein, the phenyl, phenoxy, and heterocyclic compounds are either unsubstituted or substituted by one to three identical or different substituents selected from chlorine, fluorine, bromine, methyl, cyclopropyl, difluoromethyl, trifluoromethyl, methoxy, ethoxy, or propoxy. R 8 Independently selected from hydrogen, C1-C6-alkyl, C3-C6-cycloalkyl, phenyl, and C1-C6-alkoxy; R 9 The group is selected from hydrogen, C1-C6-alkyl, C1-C6-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkyl-C1-C6-alkyl, phenyl and 5-6 membered heteroaromatic rings; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different groups selected from methyl, methoxy or halogen; R 10 Selected from halogens, -OH, -N(R) 8 2. C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 11 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, benzyl, and phenyl; R 12 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 13 Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, phenyl and 5-6 membered heteroaromatic rings; R 8a Selected from hydrogen, C1-C6 alkyl, C3-C6 cycloalkyl, and C1-C6 alkoxy; R 9a The group is selected from hydrogen, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 cycloalkyl-C1-C6 alkyl, pyridyl, and phenyl; wherein the phenyl group is unsubstituted or substituted by 1 to 3 identical or different groups selected from methyl, methoxy, or halogen; R 10a Selected from halogens, OH, C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C6 cycloalkyl-C1-C6 alkyl; R 11a Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl; R 12a Selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl; R 13a It is selected from C1-C6 alkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl and C3-C6 cycloalkyl-C1-C6 alkyl.

2. The compound of formula (I) according to claim 1, wherein, A 1 is O.

3. The compound of formula (I) according to claim 1 or 2, wherein, R 1 It is selected from hydrogen, halogen, methyl, ethyl and propyl.

4. The compound of formula (I) according to any one of the preceding claims, wherein, R 2 Selected from hydrogen, halogens, and methyl.

5. The compound of formula (I) according to any one of the preceding claims, wherein, R 3 It is hydrogen.

6. The compound of formula (I) according to any one of the preceding claims, wherein, R 4 Selected from hydrogen, halogen, cyano, C1-C8-alkyl, C2-C6-alkenyl, C2-C6-alkynyl, C1-C6-haloalkyl, C2-C6-haloalkenyl, C2-C6-haloalkynyl, C3-C8-cycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkoxy-C1-C3-alkyl, C1-C6-alkoxy, C1-C6-haloalkoxy, C3-C6-cycloalkoxy, C1-C6-alkylthio, C3-C6-cycloalkyl-C1-C4-alkyl, C1-C6-alkoxy-C1-C3-alkyl, -(CHR) 3 ) 0- 2C(R 6 )=NOR 11 -NR 8 R 9 -NR 8 COR 10 -(CHR) 3 ) 0-2 COR 9 -(CHR) 3 ) 0-2 COOR 6 -(CHR) 3 ) 0-2 NHCOR 6a -(CHR) 3 ) 0-2 CONR 8 R 9 -(CHR) 3 ) 0-2 NHCOOR 6 , phenyl, phenyl-C1-C6-alkyl, phenoxy-C1-C3-alkyl, naphthyl, C5-C 12 The compounds include saturated or partially unsaturated bicyclic or tricyclic carbocyclic rings, 5- or 6-membered heteroaromatic rings, 8- to 10-membered bicyclic heteroaromatic rings, 4- to 10-membered non-aromatic heterocycles, 4- to 10-membered non-aromatic heterocyclic -C1-C3-alkyl, 4- to 10-membered non-aromatic heterocyclic oxy-C1-C3-alkyl, 5- or 6-membered heteroaryl -C1-C3-alkyl, 5- to 10-membered heteroaryloxy-C1-C3-alkyl, and 9- or 10-membered bicyclic heteroaromatic -C1-C3-alkyl; wherein the 4- to 10-membered non-aromatic heterocycles, 5- or 6-membered heteroaromatic rings, and 8- to 10-membered bicyclic heteroaromatic rings comprise 1, 2, or 3 independently selected from N, O, or S(O). 0-2 heteroatoms; Wherein, the R 4 The aliphatic groups are not substituted or are independently selected from R 7a The R is substituted with 1 to 4 substituents, and the R 4 The cyclic groups are not substituted or are independently selected from R 7b Substitution of 1 to 4 substituents; wherein R 3 R 6 R 8 R 9 R 10 R 11 R 6a R 7a and R 7b As defined in claim 1.

7. A method for preparing the form according to claim 1, wherein A 1 A method for a compound of formula (I) containing oxygen, the method comprising steps selected from a) to c): a) In the presence of a suitable solvent, react compound (II) with compound (VIII) to obtain compound (I), as shown in the following scheme: ; Alternatively, in the presence of a suitable coupling agent, a suitable base, and a suitable solvent, compound (II) can be reacted with compound (IX) to obtain compound (I), as shown in the following scheme: ; or, In the presence of a suitable base and a suitable solvent, compound (II) is reacted with compound (X) to obtain compound (I), as shown in the following scheme: ; b) Optionally, in the presence of a suitable base and a suitable solvent, the compound of formula (III) is reacted with an aqueous solution of hydroxylamine or hydroxylamine hydrochloride to give the compound of formula (II), as shown in the following scheme: ; c) In the presence of a suitable base, a suitable metal catalyst, and a suitable solvent, the compound of formula (IV) is reacted with a cyanide salt via a metal-catalyzed reaction to obtain the compound of formula (III), as shown in the following scheme: , in, LG is halogen, A 1 It is oxygen, and R 1 R 2 R 3 R 4 and R 5 As defined in claim 1.

8. A method for preparing the form according to claim 1, wherein A 1 For NR A1 The method for compound of formula (I), wherein, The method includes the following steps: a) Reacting compound (I) with compound (XI-A) in a suitable solvent and at a suitable temperature to give compound (I-B1): Among them, R 1 R 2 R 3 R 4 R A1 and R 5 As defined in claim 1.

9. A compound of formula (Z); in, R 1 R 2 R 3 A 1 and R 5 As defined in claim 1.

10. A composition for controlling and / or preventing plant pathogenic microorganisms, comprising a compound of formula (I) as claimed in claim 1, its stereoisomers, polymorphs, N-oxides or salts, and one or more inert carriers.

11. The composition of claim 10, wherein, The concentration of compound of formula (I) relative to the total weight of the composition is 1 to 99% by weight.

12. The compound of formula (I) according to claim 1, its stereoisomers, polymorphs, N-oxides or salts, and the composition according to claim 10, for controlling or preventing crop and / or horticultural crops from being attacked by plant pathogenic fungi.

13. A seed comprising the compound of formula (I) according to claim 1, its stereoisomers, polymorphs, N-oxides or salts, wherein the amount of the compound of formula (I), its stereoisomers, polymorphs or salts is from 0.1 g to 1 kg per 100 kg of seed.

14. A method for controlling or preventing infection by plant pathogenic fungi in crops and / or horticultural crops, wherein, The compound of formula (I) according to claim 1, its stereoisomers, metal complexes, polymorphs, N-oxides or salts, or the composition according to claim 10 are applied to plants, parts or locations thereof.

Citation Information

Patent Citations

  • Disease-resistant transgenic plants

    EP0392225A2

  • Plant disease control method

    JP2020079269A

  • Enhanced herbicide composition

    US6919298B2

  • Fungicidal compounds having a fluorovinyloxyphenyl moiety and process for the preparation thereof

    WO1999007665A1

  • Hydroximic acid derivatives, process for their preparation and intermediates therefor

    WO1999067209A1